<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Long‐term antibiotics for preventing recurrent urinary tract infection in children - Williams, G - 2019 | Cochrane Library</title> <meta content="Long‐term antibiotics for preventing recurrent urinary tract infection in children - Williams, G - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001534.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Long‐term antibiotics for preventing recurrent urinary tract infection in children - Williams, G - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001534.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001534.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Long‐term antibiotics for preventing recurrent urinary tract infection in children" name="citation_title"/> <meta content="Gabrielle Williams" name="citation_author"/> <meta content="The Children's Hospital at Westmead" name="citation_author_institution"/> <meta content="gabrielle.williams@sydney.edu.au" name="citation_author_email"/> <meta content="Jonathan C Craig" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="4" name="citation_issue"/> <meta content="10.1002/14651858.CD001534.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/04/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001534.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001534.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001534.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Infective Agents, Urinary [*therapeutic use]; Antibiotic Prophylaxis; Drug Therapy, Combination; Randomized Controlled Trials as Topic; Recurrence; Secondary Prevention; Urinary Tract Infections [drug therapy, *prevention &amp; control]; Vesico-Ureteral Reflux [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001534.pub4&amp;doi=10.1002/14651858.CD001534.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="IYhCEbRn";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001534\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001534\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","ru","pt","ms","zh_HANS","fa","fr","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001534.pub4",title:"Long\\u2010term antibiotics for preventing recurrent urinary tract infection in children",firstPublishedDate:"Apr 1, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001534.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001534.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001534.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001534.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001534.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001534.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pt&quot;,&quot;title&quot;:&quot;Resumo para leigos&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001534.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001534.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001534.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001534.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>19664 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001534.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0007"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0001"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0002"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0003"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0004"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0005"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-sec1-0006"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/appendices#CD001534-sec1-0012"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/table_n/CD001534StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/table_n/CD001534StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Long‐term antibiotics for preventing recurrent urinary tract infection in children</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information#CD001534-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Gabrielle Williams</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information#CD001534-cr-0003">Jonathan C Craig</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information/en#CD001534-sec1-0017">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 April 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001534.pub4">https://doi.org/10.1002/14651858.CD001534.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001534-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001534-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001534-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001534-abs-0003">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001534-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001534-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001534-abs-0001" lang="en"> <section id="CD001534-abs1-0001"> <h3 class="title" id="CD001534-abs1-0001">Background</h3> <p>Urinary tract infection (UTI) is common in children. Symptoms include fever, lethargy, anorexia, and vomiting. UTI is caused by <i>Escherichia coli</i> in over 80% of cases and treatment is a course of antibiotics. Due to acute illness caused by UTI and the risk of pyelonephritis‐induced permanent kidney damage, many children are given long‐term (several months to 2 years) antibiotics aimed at preventing recurrence. This is the third update of a review first published in 2001 and updated in 2006, and 2011. </p> </section> <section id="CD001534-abs1-0002"> <h3 class="title" id="CD001534-abs1-0002">Objectives</h3> <p>To assess whether long‐term antibiotic prophylaxis was more effective than placebo/no treatment in preventing recurrence of UTI in children, and if so which antibiotic in clinical use was the most effective. We also assessed the harms of long‐term antibiotic treatment. </p> </section> <section id="CD001534-abs1-0003"> <h3 class="title" id="CD001534-abs1-0003">Search methods</h3> <p>We searched the Cochrane Kidney and Transplant Register of Studies up to 30 July 2018 through contact with the Cochrane Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal, and ClinicalTrials.gov. </p> </section> <section id="CD001534-abs1-0004"> <h3 class="title" id="CD001534-abs1-0004">Selection criteria</h3> <p>Randomised comparisons of antibiotics with other antibiotics, placebo or no treatment to prevent recurrent UTI in children. </p> </section> <section id="CD001534-abs1-0005"> <h3 class="title" id="CD001534-abs1-0005">Data collection and analysis</h3> <p>Two authors independently assessed and extracted information for the initial and previous updates. A random‐effects model was used to estimate risk ratio (RR) and risk difference (RD) for recurrent UTI with 95% confidence intervals (CI). </p> </section> <section id="CD001534-abs1-0006"> <h3 class="title" id="CD001534-abs1-0006">Main results</h3> <p>In this update sixteen studies (2036 children randomised, 1977 analysed) were included. Seven studies (612 children) compared two or more types of antibiotics, six (1088 children) compared antibiotics with placebo or no treatment, one four‐armed study compared circumcision with and without antibiotic treatment, one study compared dose of antibiotic, and one three‐armed study compared two different antibiotics as well as no treatment. Of the sixteen included studies only one study was judged to be at low risk of bias for all domains, with the majority judged to be at unclear risk of bias due to very poorly reported methodology. The number of studies judged to be a low risk of bias was: selection bias (7); performance bias (4); detection bias (1); attrition bias (6); reporting bias (7); and other bias (2). The number of studies judged to be at high risk of bias was: selection bias (0); performance bias (5); detection bias (1); attrition bias (4); reporting bias (6); and other bias (1). </p> <p>Compared to placebo/no treatment, antibiotics lead to a modest decrease in the number of repeat symptomatic UTI in children; however the estimate from combining all studies was not certain and the confidence interval indicates low precision indicating that antibiotics may make little or no difference to risk of repeat infection (RR 0.75, 95% CI 0.28 to 1.98). When we combined only the data from studies with concealed treatment allocation, there was a similar reduction in risk of repeat symptomatic UTI in children taking antibiotics (RR 0.68) and we have greater certainty in this estimate because of the more robust study designs, the confidence interval is smaller and it does not include the point of no effect (95% CI 0.48 to 0.95). The estimated reduction in risk of repeat symptomatic UTI for children taking antibiotics was similar in children with vesicoureteric reflux (VUR) (RR 0.65, 95% CI 0.39 to 1.07) compared to those without VUR (RR 0.56, 95% CI 0.15 to 2.12) however there was considerable uncertainty due to imprecision from fewer events in the smaller group of children with VUR. There was no consistency in occurrence of adverse events, with one study having more events in the placebo group and a second study having more events in the antibiotics group. Three studies reported data for antibiotic resistance with the analysis estimating the risk of a UTI caused by a bacteria resistant to the prophylactic antibiotic being almost 2.5 times greater in children on antibiotics than for children on placebo or no treatment (RR 2.40, 95% CI 0.62 to 9.26). However the confidence interval is wide, showing imprecision and there may be little or no difference between the two groups. </p> <p>Eight studies involving 659 children compared one antibiotic with another but few studies compared the same combination for the same outcome so little data could be pooled. Two studies reported microbial resistance data and analysis showed that treatment with nitrofurantoin may lead to a lower risk of a UTI caused by a bacteria resistant to the treatment drug compared to children given trimethoprim‐sulphamethoxazole as their prophylactic treatment (RR 0.54, 95% CI 0.31 to 0.92). </p> </section> <section id="CD001534-abs1-0007"> <h3 class="title" id="CD001534-abs1-0007">Authors' conclusions</h3> <p>Long‐term antibiotics may reduce the risk of repeat symptomatic UTI in children who have had one or more previous UTIs but the benefit may be small and must be considered together with the increased risk of microbial resistance. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001534-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001534-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001534-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001534-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001534-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001534-abs-0009">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pt#CD001534-abs-0008">Português</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001534-abs-0007">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001534-abs-0010">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001534-abs-0013">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001534-abs-0006" lang="en"> <h3>Long‐term antibiotics for preventing recurrent urinary tract infection in children</h3> <p><b>What is the issue?</b> </p> <p>Bladder and kidney infections (urinary tract infection ‐ UTI) are common in children, especially girls. They cause an uncomfortable illness that can include vomiting, fever and tiredness. In some children kidney damage may occur, as can repeat illnesses. With repeated infections the risk of kidney damage increases. Some doctors prescribe long‐term antibiotics to try to prevent infections recurring, but this may cause the child to be unwell in other ways, e.g. vomiting </p> <p><b>What did we do?</b> </p> <p>We searched electronic databases and reference lists to identify and summarise findings from all randomised controlled trials that compared low dose antibiotics given for at least 2 months, with no treatment or a placebo in children at risk of a UTI. We also identified studies comparing different types and doses of antibiotics. </p> <p><b>What did we find?</b> </p> <p>We included 16 studies (2036 children randomised, 1977 analysed). This review found that long‐term antibiotics may reduce the risk of repeat symptomatic infections but the benefit is probably small and must be weighed against the likelihood that future infections are likely to be caused by bacteria that are resistant to the antibiotic given. </p> <p><b>Conclusions</b> </p> <p>Long‐term, low dose antibiotics to prevent repeat UTI should be reserved for those children at high risk of repeat infection, such as young infants, and children clinicians would strongly want to reduce the risk of further infections, such as children with renal abnormalities. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001534-sec1-0007" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001534-sec1-0007"></div> <h3 class="title" id="CD001534-sec1-0008">Implications for practice</h3> <section id="CD001534-sec1-0008"> <p>Prior to <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> and <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>, the evidence to support long‐term, low dose antibiotics for the prevention of recurrent UTI in children without VUR consisted of a small number of poor quality studies that gave inconsistent and imprecise results. The addition of data from two much larger and better designed studies changes this. Analysis of the larger, better designed studies demonstrates, with considerable consistency, a small benefit of low dose antibiotics to prevent repeat symptomatic UTI in children. The data show few adverse effects from the antibiotic treatment but demonstrate an increased risk of bacterial resistance to the treatment drug in subsequent infections. A single study reported event time periods and showed that the greatest risk of repeat symptomatic infection occurs in the three to six months following initial UTI. Nitrofurantoin appeared the most effective treatment but led to considerable adverse events. </p> </section> <h3 class="title" id="CD001534-sec1-0009">Implications for research</h3> <section id="CD001534-sec1-0009"> <p>These findings suggest a small benefit to treating children who have had at least one UTI but for many children in the studies, no further UTIs occurred. Future research could focus on exploring and identifying which children are most likely to benefit from treatment. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001534-sec1-0001" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001534-sec1-0001"></div> <div class="table" id="CD001534-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment versus placebo or no treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antibiotic treatment versus placebo or no treatment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with previous UTI and most do not have a renal tract abnormality such as VUR<br/> <b>Setting:</b> children in the community presenting to a hospital who have experienced at least one UTI<br/> <b>Intervention:</b> antibiotic treatment<br/> <b>Comparison:</b> placebo/no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>159 per 1,000<br/> (59 to 420) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.75<br/> (0.28 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1074 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies comparing antibiotic treatment with placebo or no treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children without VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>134 per 1,000<br/> (29 to 611) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.60<br/> (0.13 to 2.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>541 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children with VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1,000<br/> (70 to 192) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.65<br/> (0.39 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size because only two studies reported separated data and majority of children did not have VUR </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children, in studies with adequate allocation concealment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1,000<br/> (77 to 153) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.68<br/> (0.48 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>914 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>4</sup><br/> MODERATE </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine culture</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>386 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1,000<br/> (31 to 455) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.31<br/> (0.08 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1,000<br/> (1 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.31<br/> (0.03 to 170.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>914 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>394 per 1,000<br/> (102 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.40<br/> (0.62 to 9.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two studies were consistent with each other but three others were quite variable in their findings </p> <p><sup>2</sup> Several studies were small and results variable, making the confidence intervals wide </p> <p><sup>3</sup> Smaller and older studies were quite variable in their findings, did not use blinding and patient selection was unclear </p> <p><sup>4</sup>One study was open label suggesting interpretation bias </p> <p><sup>5</sup> Studies which did not include symptoms in the diagnosis of UTI are likely to involve misclassification of UTI and asymptomatic bacteriuria </p> <p><sup>6</sup> One study was open label and all adverse events were in the active arm, suggesting interpretation bias </p> <p><sup>7</sup> One study conducted screening cultures and therefore examined more samples that may have been from asymptomatic bacteriuria while also demonstrating the presence of a drug resistant organism </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001534-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with primarily normal renal tracts who have experienced at least one UTI<br/> <b>Setting:</b> children who have experienced a UTI in the community and are considered for preventative treatment to reduce the risk of further UTIs<br/> <b>Intervention:</b> one type of antibiotic<br/> <b>Comparison:</b> second type of antibiotic </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic 2</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic 1</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: nitrofurantoin (1) versus cotrimoxazole (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1,000<br/> (76 to 201) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.57<br/> (0.35 to 0.92) (favours nitrofurantoin) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>157 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events were recorded in one study, so a single study provided data on this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: cotrimoxazole (1) versus cefadroxil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000<br/> (26 to 776) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.79<br/> (0.33 to 9.70) (favours cefadroxil) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodology details, not a highly relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: cotrimoxazole (1) versus cefprozil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1,000<br/> (41 to 492) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.69<br/> (0.20 to 2.39) (favours cotrimoxazole) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodological details, not a very relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drugs: nitrofurantoin (1) versus cotrimoxazole (2) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>672 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>363 per 1,000<br/> (208 to 618) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.54<br/> (0.31 to 0.92) (favours nitrofurantoin) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had limited methodology reported, but were consistent in their findings</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: cotrimoxazole (1) versus cefprozil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>88 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000<br/> (32 to 643) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.62<br/> (0.36 to 7.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodology details, not a highly relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: nitrofurantoin (1) versus trimethoprim (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>283 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>618 per 1,000<br/> (394 to 966) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.18<br/> (1.39 to 3.41) (favours trimethoprim) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, poorly reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Both studies reported their methodology very poorly and it was difficult to be certain of design issues </p> <p><sup>2</sup> Single study, no missing data but considerable uncertainty and imprecision </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001534-sec1-0002" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001534-sec1-0002"></div> <section id="CD001534-sec2-0001"> <h3 class="title" id="CD001534-sec2-0001">Description of the condition</h3> <p>Acute urinary tract infection (UTI) is common in children. By the age of seven years, 8.4% of girls and 1.7% of boys will have suffered at least one episode (<a href="./references#CD001534-bbs2-0049" title="HellstromA , HansonE , HanssonS , HjalmasK , JodalU . Association between urinary symptoms at 7 years old and previous urinary tract infection. Archives of Disease in Childhood1991;66(2):232‐4. [MEDLINE: 2001110] ">Hellstrom 1991</a>). Death is now a rare complication but hospitalisation is frequently required (40%), particularly in infancy (<a href="./references#CD001534-bbs2-0044" title="CraigJC , IrwigLM , KnightJF , SureshkumarP , RoyLP . Symptomatic urinary tract infection in preschool Australian children. Journal of Paediatrics &amp; Child Health1998;34(2):154‐9. [MEDLINE: 9588640] ">Craig 1998</a>). Transient damage to the kidneys occurs in about 40% of children (<a href="./references#CD001534-bbs2-0044" title="CraigJC , IrwigLM , KnightJF , SureshkumarP , RoyLP . Symptomatic urinary tract infection in preschool Australian children. Journal of Paediatrics &amp; Child Health1998;34(2):154‐9. [MEDLINE: 9588640] ">Craig 1998</a>), and permanent damage occurs in about 5% (<a href="./references#CD001534-bbs2-0043" title="CoulthardMG , LambertHJ , KeirMJ . Occurrence of renal scars in children after their first referral for urinary tract infection. BMJ1997;315(7113):918‐9. [MEDLINE: 9361542] ">Coulthard 1997</a>), sometimes even following a single infection. Symptoms are systemic rather than localised in early childhood and consist of fever, lethargy, anorexia, and vomiting. UTI is caused by <i>Escherichia coli</i> in over 80% of cases (<a href="./references#CD001534-bbs2-0056" title="RushtonHG . Urinary tract infections in children. Epidemiology, evaluation and management. Pediatric Clinics of North America1997;44(5):1133‐69. [MEDLINE: 9326956] ">Rushton 1997</a>) and treatment consists of a course of antibiotics. </p> <p>Children who have had one infection are at risk of further infections. Recurrent UTI occurs in up to 30% (<a href="./references#CD001534-bbs2-0059" title="WinbergJ , BergstromT , JacobssonB . Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney International ‐ Supplement1975;4:S101‐6. [MEDLINE: 1104973] ">Winberg 1975</a>). The risk factors for recurrent infection are vesicoureteric reflux (VUR), bladder instability and previous infections (<a href="./references#CD001534-bbs2-0048" title="HellersteinS . Recurrent urinary tract infections in children. Pediatric Infectious Disease1982;1(4):271‐81. [MEDLINE: 6757892] ">Hellerstein 1982</a>; <a href="./references#CD001534-bbs2-0056" title="RushtonHG . Urinary tract infections in children. Epidemiology, evaluation and management. Pediatric Clinics of North America1997;44(5):1133‐69. [MEDLINE: 9326956] ">Rushton 1997</a>). Recurrence of UTI occurs more commonly in girls than boys (<a href="./references#CD001534-bbs2-0042" title="BergstromT . Sex differences in childhood urinary tract infection. Archives of Disease in Childhood1972;47(252):227‐32. [MEDLINE: 4554084] ">Bergstrom 1972</a>; <a href="./references#CD001534-bbs2-0059" title="WinbergJ , BergstromT , JacobssonB . Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood. Kidney International ‐ Supplement1975;4:S101‐6. [MEDLINE: 1104973] ">Winberg 1975</a>). </p> <p>Due to the unpleasant acute illness caused by UTI and the risk of pyelonephritis‐induced permanent kidney damage, many children are given long‐term antibiotics aimed at preventing recurrence. Cotrimoxazole, nitrofurantoin and trimethoprim are commonly used for this purpose. These medications may cause side effects and promote the development of resistant bacteria. </p> </section> <section id="CD001534-sec2-0002"> <h3 class="title" id="CD001534-sec2-0002">Description of the intervention</h3> <p>Various low dose antibiotics have been used as prophylactic treatment in children, common options include; trimethoprim/sulphamethoxazole (2mg/kg/day /10 mg/kg/d) and nitrofurantoin (1 to 2 mg/kg/d). Other less frequently used antibiotics include cefadroxil (12.5 to 15 mg/kg/d), nalidixic acid (30 mg/kg/d), pivmecillinam (100 to 200 mg/d), cefixime (2 mg/kg), and co‐amoxiclav (15 mg/kg/d) and probably others. Durations of treatment range from one month to several years. </p> </section> <section id="CD001534-sec2-0003"> <h3 class="title" id="CD001534-sec2-0003">How the intervention might work</h3> <p>Theoretically, maintaining a small amount of antibiotic in the body could prevent bacteria growing out of control and causing illness. </p> </section> <section id="CD001534-sec2-0004"> <h3 class="title" id="CD001534-sec2-0004">Why it is important to do this review</h3> <p>Low dose antibiotic prophylaxis has been used to prevent recurring UTIs in children for many years. Anecdotal evidence and a cohort study (<a href="./references#CD001534-bbs2-0044" title="CraigJC , IrwigLM , KnightJF , SureshkumarP , RoyLP . Symptomatic urinary tract infection in preschool Australian children. Journal of Paediatrics &amp; Child Health1998;34(2):154‐9. [MEDLINE: 9588640] ">Craig 1998</a>) has suggested some children on prophylactic antibiotics experience recurrence despite the treatment and theoretical concerns over bacterial resistance to such long term use of antibiotics were also raised. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001534-sec1-0003" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001534-sec1-0003"></div> <p>To assess whether long‐term antibiotic prophylaxis was more effective than placebo/no treatment in preventing recurrence of UTI in children, and if so which antibiotic in clinical use was the most effective. We also assessed the harms of long‐term antibiotic treatment. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001534-sec1-0004" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001534-sec1-0004"></div> <section id="CD001534-sec2-0005"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001534-sec3-0001"> <h4 class="title">Types of studies</h4> <p> <ul id="CD001534-lst1-0001"> <li> <p>All randomised controlled trials (RCTs) and quasi‐RCTs (allocation based on alternation, date of birth, hospital medical record number) of antibiotic treatment versus placebo/no treatment for the prevention of recurrent UTI. </p> </li> <li> <p>All RCTs and quasi‐RCTs that compared two or more antibiotics administered daily for a period of at least two months for the prevention of recurrent UTI were included. </p> </li> </ul> </p> </section> <section id="CD001534-sec3-0002"> <h4 class="title">Types of participants</h4> <p>Children less than 18 years of age who were at risk of recurrence due to prior infection were included. Studies were included if the majority of participants (&gt; 50%) did not have a predisposing cause such as a renal tract abnormality, including VUR, or a major neurological, urological or muscular disease. </p> </section> <section id="CD001534-sec3-0003"> <h4 class="title">Types of interventions</h4> <p>Long‐term antibiotic versus placebo/no treatment, and studies that compared two or more antibiotics with each other. Long‐term prophylaxis was defined as antibiotic administered daily for a period of at least two months. </p> </section> <section id="CD001534-sec3-0004"> <h4 class="title">Types of outcome measures</h4> <section id="CD001534-sec4-0001"> <h5 class="title">Primary outcomes</h5> <p>The primary outcome was the number of repeat symptomatic UTIs, confirmed by bacterial growth in the urine, in combination with signs or symptoms of a urine infection while on treatment/placebo. </p> </section> <section id="CD001534-sec4-0002"> <h5 class="title">Secondary outcomes</h5> <p>The secondary outcomes were total number of positive urine cultures, adverse reactions to treatment, hospitalisation with UTI and microbial resistance. </p> </section> </section> </section> <section id="CD001534-sec2-0006"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001534-sec3-0005"> <h4 class="title">Electronic searches</h4> <p>We searched the <a href="http://kidneyandtransplant.cochrane.org/cochrane-kidney-and-transplant-specialised-register" target="_blank">Cochrane Kidney and Transplant Register of Studies</a> up to 30 July 2018 through contact with the Information Specialist using search terms relevant to this review. The Register of Studies contains studies identified from the following sources. </p> <p> <ol id="CD001534-lst1-0002"> <li> <p>Monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL)</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searches of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney and transplant journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Register are identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies, as well as a list of handsearched journals, conference proceedings and current awareness alerts, are available in the Specialised Register section of information about <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD001534-sec2-0016">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD001534-sec3-0006"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD001534-lst1-0003"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters seeking information about unpublished or incomplete studies to investigators known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD001534-sec2-0007"> <h3 class="title" id="CD001534-sec2-0007">Data collection and analysis</h3> <section id="CD001534-sec3-0007"> <h4 class="title">Selection of studies</h4> <section id="CD001534-sec4-0003"> <h5 class="title">2018 review update</h5> <p>The search results were screened and studies included or excluded based on the selection criteria listed above. Data extraction and text were completed by one author. Since both authors on this review are also authors on an included study (<a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>), risk of bias assessment was independently reviewed by Narelle Willis (Cochrane Kidney and Transplant). </p> </section> <section id="CD001534-sec4-0004"> <h5 class="title">Initial review (2001) and previous updates (2006, 2011)</h5> <p>The search strategy described above was used independently by two authors to obtain titles of abstracts relevant to the review. The titles were independently screened by two authors, who discarded studies that were irrelevant. The selection was overly inclusive to ensure no relevant studies were missed. Two authors screened the resulting list of articles independently to assess whether the studies met our inclusion criteria. Disagreements were resolved by discussion with a third author. </p> </section> </section> <section id="CD001534-sec3-0008"> <h4 class="title">Data extraction and management</h4> <p>Full articles of the included studies were examined, under open conditions to extract the necessary information. Methods (participant details (numbers, age, gender), type of antibiotic, frequency and dose regimen, duration of treatment, outcomes (recurrent UTI, adverse reactions to treatment) were extracted. Discrepancies in data extraction were resolved by discussion. </p> </section> <section id="CD001534-sec3-0009"> <h4 class="title">Assessment of risk of bias in included studies</h4> <section id="CD001534-sec4-0005"> <h5 class="title">Review updates (2011, 2018)</h5> <p>For the 2018 and 2011 updates the risk of bias tables were completed. The following items were assessed by using the risk of bias assessment tool (<a href="./references#CD001534-bbs2-0051" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (<i>see</i><a href="./appendices#CD001534-sec2-0017">Appendix 2</a>). </p> <p> <ul id="CD001534-lst1-0004"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD001534-lst2-0001"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD001534-sec4-0006"> <h5 class="title">Initial review (2001) and 2006 update</h5> <p>The quality of eligible studies was assessed independently, under open conditions by two of three authors with disagreements resolved after consultation with a third author. Blinding, losses to follow‐up, heterogeneity of study group participants, standardisation of outcome assessment, and whether intention‐to‐treat analysis was conducted, were assessed (<a href="./references#CD001534-bbs2-0060" title="WilliamsGJ , LeeA , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD001534] ">Williams 2001</a>; <a href="./references#CD001534-bbs2-0061" title="WilliamsG , WeiL , LeeA , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD001534.pub2] ">Williams 2006</a>). </p> </section> </section> <section id="CD001534-sec3-0010"> <h4 class="title">Measures of treatment effect</h4> <p>The primary outcome was the proportion of patients experiencing a recurrence of symptomatic UTI. The results of each study were calculated as point estimates with their corresponding 95% confidence intervals (CI). The risk ratio (RR) and risk difference (RD) were used as the measures of summary treatment effects. Number needed‐to‐treat (NNT) and number needed‐to‐harm (NNH) estimates (1/RD) were calculated to compare the benefits and harmful effects of antibiotics. Analyses were conducted for studies: </p> <p> <ul id="CD001534-lst1-0005"> <li> <p>Comparing antibiotics with placebo/no treatment</p> </li> <li> <p>Comparing one type of antibiotic with another type.</p> </li> </ul> </p> </section> <section id="CD001534-sec3-0011"> <h4 class="title">Dealing with missing data</h4> <p>Further information was sought from authors where papers did not contain sufficient information to make an appropriate decision about inclusion. </p> </section> <section id="CD001534-sec3-0012"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed the heterogeneity by visual inspection of the forest plot. Heterogeneity was analysed using a Chi<sup>2</sup> test on N‐1 degrees of freedom, with an alpha of 0.05 used for statistical significance and with the I<sup>2</sup> test (<a href="./references#CD001534-bbs2-0050" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). A guide to the interpretation of I<sup>2</sup> values is as follows. </p> <p> <ul id="CD001534-lst1-0006"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity.</p> </li> </ul> </p> <p>The importance of the observed value of I<sup>2</sup> depends on the magnitude and direction of treatment effects and the strength of evidence for heterogeneity (e.g. P‐value from the Chi<sup>2</sup> test, or a CI for I<sup>2</sup>) (<a href="./references#CD001534-bbs2-0051" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD001534-sec3-0013"> <h4 class="title">Assessment of reporting biases</h4> <p>Publication bias was to be assessed using a funnel plot; however there were insufficient studies to carry out this assessment. </p> </section> <section id="CD001534-sec3-0014"> <h4 class="title">Data synthesis</h4> <p>Results were pooled using a random effects model.</p> </section> <section id="CD001534-sec3-0015"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Univariate analyses were used to explore the antibiotic treatment effect on repeat symptomatic UTI. Subgroup analysis was used to examine how patients VUR status and study quality (risk of bias table fields) influenced the summary treatment effect. </p> <section id="CD001534-sec4-0007"> <h5 class="title">'Summary of findings' tables</h5> <p>We presented the main results of the review in 'Summary of findings' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes (<a href="./references#CD001534-bbs2-0057" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and 'Summary of findings' tables. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011a</a>). The 'Summary of findings' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach (<a href="./references#CD001534-bbs2-0046" title="GuyattGH , OxmanAD , VistGE , KunzR , Falck‐YtterY , Alonso‐CoelloP , et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ2008;336(7650):924‐6. [MEDLINE: 18436948] ">GRADE 2008</a>; <a href="./references#CD001534-bbs2-0047" title="GuyattG , OxmanAD , AklEA , KunzR , VistG , BrozekJ , et al. GRADE guidelines: 1. Introduction‐GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology2011;64(4):383‐94. [MEDLINE: 22818160] ">GRADE 2011</a>). The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates and risk of publication bias (<a href="./references#CD001534-bbs2-0058" title="SchünemannHJ , OxmanAD , HigginsJP , DeeksJJ , GlasziouP , GuyattGH . Chapter 12: Interpreting results and drawing conclusions. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011b</a>). We presented the following outcomes in the 'Summary of findings' tables. </p> <p> <ul id="CD001534-lst1-0007"> <li> <p>Recurrence of symptomatic UTI in children</p> </li> <li> <p>Recurrence of symptomatic UTI in children without VUR</p> </li> <li> <p>Recurrence of symptomatic UTI in children with VUR</p> </li> <li> <p>Recurrence of symptomatic UTI in children, in studies with adequate allocation concealment</p> </li> <li> <p>Repeat positive urine culture</p> </li> <li> <p>All adverse events</p> </li> <li> <p>Microbial resistance to prophylactic drug.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001534-sec1-0005" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001534-sec1-0005"></div> <section id="CD001534-sec2-0008"> <h3 class="title">Description of studies</h3> <section id="CD001534-sec3-0016"> <h4 class="title">Results of the search</h4> <p><b>2018 review update</b> </p> <p>The search of the specialised register of the Cochrane Kidney and Transplant group identified 59 reports of studies. An alert in Research Gate identified a report of an eligible study (<a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>) that was not identified in the Specialised Register and was not listed in MEDLINE or PubMed and was incorrectly coded in EMBASE as a journal article instead of a trial. After title and abstract review 25 reports underwent full text review (<a href="#CD001534-fig-0001">Figure 1</a>). Four new eligible studies (5 reports) were included (<a href="./references#CD001534-bbs2-0001" title="AntachopoulosC , IonnidouM , TratselasA , IosifidisE , KatragkouA , KadiltzoglouP , et al. Comparison of cotrimoxazole vs. second‐generation cephalosporins for prevention of urinary tract infections in children. Pediatric Nephrology2016;31(12):2271‐76. [MEDLINE: 27525699] ">Antachopoulos 2016</a>; <a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a>; <a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>), six new reports of five already included studies were identified (<a href="./references#CD001534-bbs2-0002" title="BaciulisV , EitutieneG , BaciulieneE , CerkauskieneR , JankauskieneA . Long‐term cefadroxil prophylaxis in children with recurrent urinary tract infections [abstract no: W832]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816. BaciulisV , EitutieneG , CerkauskieneR , BaciulieneE , JankauskieneA , MieliauskaiteE . Long term cefadroxil prophylaxis in children with recurrent urinary tract infections [Vaiku pasikartojancios slapimo organu infekcijos ilgalaikis profilaktinis gydymas cefadroksiliu]. Medicina2003;39(Suppl 1):59‐63. [MEDLINE: 12761422] ">Baciulis 2003</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>), and we excluded 49 reports (24 reports of 11 new studies and 25 reports of 2 already excluded studies). </p> <div class="figure" id="CD001534-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001534-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p><b>2011 review update</b> </p> <p>The specialised register search identified 30 reports. After title, abstract and then full‐text review we identified five reports of four new included studies (<a href="./references#CD001534-bbs2-0002" title="BaciulisV , EitutieneG , BaciulieneE , CerkauskieneR , JankauskieneA . Long‐term cefadroxil prophylaxis in children with recurrent urinary tract infections [abstract no: W832]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816. BaciulisV , EitutieneG , CerkauskieneR , BaciulieneE , JankauskieneA , MieliauskaiteE . Long term cefadroxil prophylaxis in children with recurrent urinary tract infections [Vaiku pasikartojancios slapimo organu infekcijos ilgalaikis profilaktinis gydymas cefadroksiliu]. Medicina2003;39(Suppl 1):59‐63. [MEDLINE: 12761422] ">Baciulis 2003</a>; <a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a>; <a href="./references#CD001534-bbs2-0007" title="FalakaflakiB , FallahR , JamshidiMR , MoeziF , TorabiZ . Comparison of nitrofurantoin and trimethoprim‐sulphamethoxazole for long‐term prophylaxis in children with recurrent urinary tract infections. International Journal of Pharmacology2007;3(2):179‐82. [EMBASE: 2007450479] ">Falakaflaki 2007</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>), two reports of an existing included study (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>), three reports of one ongoing study (<a href="./references#CD001534-bbs2-0037" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl 1):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MattooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐e21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] PierceK , HainsDS , CreacyS , SchwadererAL , BecknellB , SpencerJD . Polymorphisms in antimicrobial peptide, ribonuclease 7, associate with urinary tract infection risk [abstract no: FR‐OR089]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):55A. RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract no: MP54‐03]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152982. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJC . Randomised controlled trial: RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence‐Based Medicine2014;19(6):229‐30. [EMBASE: 2014919971] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>) and 20 reports of nine new excluded studies. </p> <p><b>2006 review update</b> </p> <p>The search identified three new reports. We identified two new eligible studies (<a href="./references#CD001534-bbs2-0009" title="LeggtenB , TrosterK . Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin [Reinfektionsprophylaxe rezidivierender Harnwegsinfektionen im Kindesalter ‐ Ergebnisse einer offenen, kontrollierten und randomisierten Studie zur Wirksamkeit und Vertraglichkeit von Cefixim im Vergleich zu Nitrofurantoin]. Klinische Padiatrie2002;214(6):353‐8. [MEDLINE: 12424684] ">Lettgen 2002</a>; and an early abstract of <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>) and tow previously excluded studies were re‐assessed and included in this update (<a href="./references#CD001534-bbs2-0006" title="CarlsenNL , HesselbjergU , GlentingP . Comparison of long‐term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children: an open, randomized, cross‐over study. Journal of Antimicrobial Chemotherapy1985;16(4):509‐17. [MEDLINE: 4066562] ">Carlsen 1985</a>; <a href="./references#CD001534-bbs2-0011" title="LohrJA , NunleyDH , HowardsSS , FordRF . Prevention of recurrent urinary tract infections in girls. Pediatrics1977;59(4):562‐5. [MEDLINE: 322082] ">Lohr 1977</a>). One report was excluded. </p> <p><b>Initial review (2001)</b> </p> <p>Of &gt; 900 titles screened, 595 abstracts were reviewed with 578 excluded because they were clearly not RCTs of antibiotic treatment in children with UTI. Seventeen reports underwent full text review; four met our inclusion criteria (<a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>), one study was awaiting translation, and 12 studies were excluded. </p> </section> <section id="CD001534-sec3-0017"> <h4 class="title">Included studies</h4> <p>Sixteen studies (2036 randomised children, 1977 analysed) were identified (see <a href="./references#CD001534-sec2-0021" title="">Characteristics of included studies</a>) </p> <p>Thirteen studies used a parallel design while three were cross‐over studies. Thirteen studies compared two treatment groups, two studies compared three treatments and one study compared four treatment options. Seven studies (612 children) compared two or more types of antibiotics only, six studies (1088 children) compared antibiotics with placebo or not treatment, one four‐armed study (197 children) compared circumcision with and without antibiotic treatment; one study (33 children) compared dose of antibiotic (every night versus alternate night) and one three‐armed study (47 children) compared two different antibiotics as well as no treatment. </p> <p>Duration of antibiotic prophylaxis varied from 10 weeks to 12 months. Thirteen studies reported the number of children with VUR (a total of 637) and 15 studies reported numbers of girls and boys (1246 girls and 669 boys). Seven studies recruited children who had experienced one or more UTIs, three studies recruited after the child's first UTI and one study included girls without a UTI but with bacteriuria. In five studies UTI history at enrolment was not reported. </p> </section> <section id="CD001534-sec3-0018"> <h4 class="title">Excluded studies</h4> <p>Fourteen studies enrolled &gt; 50% of children with VUR (<a href="./references#CD001534-bbs2-0021" title="Espino HernandezM , AresesR , Garcia MeseguerC , PenaA , MelgosaM , RuperezM , et . Antibiotic prophylaxis in high degree vesicoureteral reflux. Prospective, randomized and multicentric study, preliminary results [abstract no: P10]. Pediatric Nephrology2012;27(9):1648‐9. HernandezME , ArcosGB , HijosaMM , OlondrizBO , PenaA , Do FornoAR , et al. Antibiotic prophylaxis in high degree vesicoureteral reflux clinical trial and prospective, observational and multicentric study [abstract no: O80]. Pediatric Nephrology2014;29(9):1684. [EMBASE: 71662394] ">Espino Hernandez 2012</a>; <a href="./references#CD001534-bbs2-0022" title="FeldmanW , JohnsonDM , NewberryP , WeldonA , NaidooS . Comparison of trimethoprim‐sulfamethoxazole with sulfamethoxazole in urinary tract infections of children. Canadian Medical Association Journal1975;112(13 Spec No):19‐21. [MEDLINE: 1093648] ">Feldman 1975</a>; <a href="./references#CD001534-bbs2-0026" title="Habeeb AbidM . Comparative study between the use of dextranomer hyaluronic acid copolymer (Dexel) versus polyacrylate polyalcohol copolymer (Vantris) in the endoscopic treatment of vesicoureteral reflux (VUR) in children. European Urology, Supplements2015;14(2):e504. [EMBASE: 71831430] ">Habeeb Abid 2015</a>; <a href="./references#CD001534-bbs2-0027" title="HariP , HariS , SinhaA , KumarR , KapilA , BaggaA . Antibiotic prophylaxis in management of vesicoureteric reflux: a double‐blind placebo controlled trial [abstract no: O‐43]. Pediatric Nephrology2013;28(8):1363. [EMBASE: 71126984] HariP , HariS , SinhaA , KumarR , KapilA , PandeyRM , et al. Antibiotic prophylaxis in the management of vesicoureteric reflux: a randomized double‐blind placebo‐controlled trial. Pediatric Nephrology2015;30(3):479‐86. [MEDLINE: 25173357] ">Hari 2015</a>; <a href="./references#CD001534-bbs2-0028" title="LeeSJ , KimHJ , ShimYH , LeeJW . The effect of probiotic prophylaxis for preventing recurrent urinary tract infection in children with persistent primary vesicoureteral reflux [abstract no: COD.PP 81]. Pediatric Nephrology2006;21(10):1542. [CENTRAL: CN‐00724966] LeeSJ , ShimYH , ChoSJ , LeeJW . Probiotics prophylaxis in children with persistent primary vesicoureteral reflux. Pediatric Nephrology2007;22(9):1315‐20. [MEDLINE: 17530295] ">Lee 2007a</a>; <a href="./references#CD001534-bbs2-0032" title="MohseniMJ , AryanZ , Emamzadeh‐FardS , PaydaryK , MofidV , JoudakiH , et al. Combination of probiotics and antibiotics in the prevention of recurrent urinary tract infection in children. Iranian Journal of Pediatrics2013;23(4):430‐8. [MEDLINE: 24427497] ">Mohseni 2013</a>; <a href="./references#CD001534-bbs2-0034" title="PennesiM , PeratonerL , BordugoA , SaccariA , MinisiniS , TravanL . Uneffectiveness of antibiotic prophylaxis in children with vesicoureteral reflux. Preliminary data from a controlled study [abstract no: MP239]. Nephrology Dialysis Transplantation2006;21(Suppl 4):iv378. [CENTRAL: CN‐00602044] PennesiM , PeratonerL , GiacominiA , TravenL , BordugoA . Uneffectiveness of antibiotic prophylaxis in children with VUR. Preliminary data from a controlled study [abstract no: COD.OC 2]. Pediatric Nephrology2006;21(10):1502. [CENTRAL: CN‐00602043] PennesiM , TravanL , PeratonerL , BordugoA , CattaneoA , RonfaniL , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;121(6):e1489‐94. [MEDLINE: 18490378] ">Pennesi 2008</a>; <a href="./references#CD001534-bbs2-0036" title="RayCG , ChingYC , ShurtleffDB , HillML , AnsellJS , WedgwoodRJ . Chronic urinary tract infections in children: a double‐blind study of medical management. Pediatrics1970;45(3):456‐61. [MEDLINE: 4910093] ">Ray 1970</a>; <a href="./references#CD001534-bbs2-0037" title="CarpenterMA , HobermanA , MattooTK , MathewsR , KerenR , ChesneyRW , et al. The RIVUR trial: profile and baseline clinical associations of children with vesicoureteral reflux. Pediatrics2013;132(1):e34‐45. [MEDLINE: 23753091] ChesneyRW , CarpenterMA , Moxey‐MimsM , NybergL , GreenfieldSP , HobermanA , et al. Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR): background commentary of RIVUR investigators. Pediatrics2008;122 Suppl 5:S233‐9. [MEDLINE: 19018047] EdmonsonMB , EickhoffJC . Weight gain and obesity in infants and young children exposed to prolonged antibiotic prophylaxis. JAMA Pediatrics2017;171(2):150‐6. [MEDLINE: 28027334] GreenfieldS , CarpenterM , HobermanA , MattooT , MathewsR , KerenR , et al. The RIVUR trial: baseline demographic and clinical characteristics [abstract no: 641]. Journal of Urology2013;189(4 Suppl 1):e262. [EMBASE: 71031583] GreenfieldSP , CarpenterMA , ChesneyRW , ZerinJM , ChowJ . The RIVUR voiding cystourethrogram pilot study: experience with radiologic reading concordance. Journal of Urology2012;188(4 Suppl):1608‐12. [MEDLINE: 22910235] KerenR . Pediatrics. RIVUR trial. Introduction. Pediatrics2008;122 Suppl 5:S231‐2. [MEDLINE: 19086141] KerenR , CarpenterM , GreenfieldS , HobermanA , MathewsR , MattooT , et al. Is antibiotic prophylaxis in children with vesicoureteral reflux effective in preventing pyelonephritis and renal scars? A randomized, controlled trial. Pediatrics2008;122(6):1409‐10. [MEDLINE: 19047267] KerenR , CarpenterMA , HobermanA , ShaikhN , MattooTK , ChesneyRW , et al. Rationale and design issues of the Randomized Intervention for Children With Vesicoureteral Reflux (RIVUR) study. Pediatrics2008;122 Suppl 5:S240‐50. [MEDLINE: 19018048] KerenR , ShaikhN , PohlH , Gravens‐MuellerL , IvanovaA , ZaoutisL , et al. Risk factors for recurrent urinary tract infection and renal scarring. Pediatrics2015;136(1):e13‐e21. [MEDLINE: 26055855] MattooT , CarpenterM , ChesneyR , GreenfieldS , HobermanA , KerenR , et al. Screening and enrolling children with vesicoureteral reflux: preliminary data from the RIVUR trial [abstract no: PS3‐SAT‐522]. Pediatric Nephrology2011;26(9):1729‐30. [EMBASE: 70530954] MattooTK . Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:8. MattooTK , CarpenterMA , Moxey‐MimsM , ChesneyRW , RIVUR Trial. The RIVUR trial: a factual interpretation of our data. Pediatric Nephrology2015;30(5):707‐12. [MEDLINE: 25558811] MattooTK , ChesneyRW , GreenfieldSP , HobermanA , KerenR , MathewsR , et al. Renal scarring in the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) Trial. Clinical Journal of the American Society of Nephrology: CJASN2016;11(1):54‐61. [MEDLINE: 26555605] NelsonCP , HobermanA , ShaikhN , KerenR , MathewsR , GreenfieldSP , et al. Antimicrobial resistance and urinary tract infection recurrence. Pediatrics2016;137(4):e20152490. [MEDLINE: 26969273] Perez‐GaxiolaG . Antibiotic prophylaxis reduced symptomatic urinary tract infection in children with vesicoureteral reflux, but not scarring. Archives of Disease in Childhood Education &amp; Practice2015;100(1):52. [MEDLINE: 25073466] PierceK , HainsDS , CreacyS , SchwadererAL , BecknellB , SpencerJD . Polymorphisms in antimicrobial peptide, ribonuclease 7, associate with urinary tract infection risk [abstract no: FR‐OR089]. Journal of the American Society of Nephrology2016;27(Abstract Suppl):55A. RIVUR Trial Investigators, HobermanA , GreenfieldSP , MattooTK , KerenR , MathewsR , et al. Antimicrobial prophylaxis for children with vesicoureteral reflux. New England Journal of Medicine2014;370(25):2367‐76. [MEDLINE: 24795142] SchaefferAJ , ChowJS , IvanovaA , CuiG , GreenfieldSP , ZerinJM , et al. Variation in the level of detail in pediatric voiding cystourethrogram reports. Journal of Pediatric Urology2017;13(3):257‐62. [MEDLINE: 28277235] SchaefferAJ , GreenfieldSP , IvanovaA , CuiG , ZerinJM , ChowJS , et al. Reliability of grading of vesicoureteral reflux and other findings on voiding cystourethrography. Journal of Pediatric Urology2017;13(2):192‐8. [MEDLINE: 27666144] SchwadererAL , WangH , KimS , KlineJM , LiangD , BrophyPD , et al. Polymorphisms in alpha‐defensin‐Encoding DEFA1A3 associate with urinary tract infection risk in children with vesicoureteral reflux. Journal of the American Society of Nephrology2016;27(10):3175‐86. [MEDLINE: 26940096] SeidemanC , LotanY , PalmerL . Cost effectiveness of antimicrobial prophylaxis for children in the RIVUR trial [abstract no: MP54‐03]. Journal of Urology2015;193(4 Suppl 1):e665. [EMBASE: 71859344] ShaikhN , HobermanA , KerenR , GotmanN , DocimoSG , MathewsR , et al. Recurrent urinary tract infections in children with bladder and bowel dysfunction. Pediatrics2016;137(1):e20152982. [MEDLINE: 26647376] ShaikhN , HobermanA , KerenR , IvanovaA , GotmanN , ChesneyRW , et al. Predictors of antimicrobial resistance among pathogens causing urinary tract infection in children. Journal of Pediatrics2016;171:116‐21. [MEDLINE: 26794472] ShaikhN , HobermanA , KerenR , IvanovaA , ZiessmanHA , CuiG , et al. Utility of sedation for young children undergoing dimercaptosuccinic acid renal scans. Pediatric Radiology2016;46(11):1573‐8. [MEDLINE: 27287454] ShaikhN , MattooTK , KerenR , IvanovaA , CuiG , Moxey‐MimsM , et al. Early antibiotic treatment for pediatric febrile urinary tract infection and renal scarring. JAMA Pediatrics2016;170(9):848‐54. [MEDLINE: 27455161] WilliamsG , CraigJC . Randomised controlled trial: RIVUR trial offers confirmatory evidence for a small but real benefit of antibiotics for UTI prevention in children. Evidence‐Based Medicine2014;19(6):229‐30. [EMBASE: 2014919971] ZiessmanHA , MajdM . Importance of methodology on (99m)technetium dimercapto‐succinic acid scintigraphic image quality: imaging pilot study for RIVUR (Randomized Intervention for Children With Vesicoureteral Reflux) multicenter investigation. Journal of Urology2009;182(1):272‐9. [MEDLINE: 19450818] ">RIVUR 2008</a>; <a href="./references#CD001534-bbs2-0038" title="DeCuntoA , PennesiM , SaliernoP . Re: Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study: G. Roussey‐Kesler, V. Gadjos, N. Idres, B. Horen, L. Ichay, M. D. Leclair, F. Raymond, A. Grellier, I. Hazart, L. De parscau, R. Salomon, G. Champion, V. Leroy, V. Guigonis, D. Siret, J. B. Palcoux,S. Taque, A. Lemoigne, J. M. Nguyen and C. Guyot. J Urol 2008; 179: 674‐679. Journal of Urology2008;180(5):2258‐9. [MEDLINE: 18804797] Roussey‐KeslerG , GadjosV , IdresN , HorenB , GuyotC . Antibiotic prophylaxis for the prevention of urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study [abstract no: 204]. Pediatric Nephrology2007;22(9):1450. [CENTRAL: CN‐00689078] Roussey‐KeslerG , GadjosV , IdresN , HorenB , IchayL , LeclairMD , et al. Antibiotic prophylaxis for the prevention of recurrent urinary tract infection in children with low grade vesicoureteral reflux: results from a prospective randomized study. Journal of Urology2008;179(2):674‐9. [MEDLINE: 18082208] ">Roussey‐Kesler 2008</a>; <a href="./references#CD001534-bbs2-0039" title="Sanchez BayleM , Barrio PerezML , Estepa SotoMR , Lopez VerdeYL . Prophylactic treatment of urinary tract infection in childhood [Eleccion de trattamiento en las infecciones urinarias recurrentes en la infancia]. Annals Espanola Pediatrica1984;20(1):28‐32. [EMBASE: 14151026] ">Sanchez‐Bayle 1983</a>; <a href="./references#CD001534-bbs2-0040" title="BrandstromP . Swedish Reflux Trial: a follow‐up [abstract]. 2nd Gothenburg Conference on Vesicoureteral Reflux; 2015 Jun 11‐12; Goteborg, Sweden. 2015:13. BrandstromP , EsbjornerE , HertheliusM , HolmdahlG , LackgrenG , NeveusT , et al. The Swedish reflux trial in children: I. Study design and study population characteristics.[Erratum appears in J Urol. 2011 Jan;185(1):365]. Journal of Urology2010;184(1):274‐9. [MEDLINE: 20478580] BrandstromP , EsbjornerE , HertheliusM , SwerkerssonS , JodalU , HanssonS . The Swedish reflux trial in children: III. Urinary tract infection pattern. Journal of Urology2010;184(1):286‐91. [MEDLINE: 20488494] BrandstromP , HanssonS . Growth in children with dilating VUR ‐ a follow up of the Swedish Reflux Trial [abstract no: P‐SAT044]. Pediatric Nephrology2013;28(8):1391. [EMBASE: 71127064] BrandstromP , JodalU , SillenU , HanssonS . The Swedish reflux trial: review of a randomized, controlled trial in children with dilating vesicoureteral reflux. Journal of Pediatric Urology2011;7(6):594‐600. [MEDLINE: 21807562] BrandstromP , NeveusT , SixtR , StoklandE , JodalU , HanssonS . The Swedish reflux trial in children: IV. Renal damage. Journal of Urology2010;184(1):292‐7. [MEDLINE: 20494369] HolmdahlG , BrandstromP , LackgrenG , SillenU , StoklandE , JodalU , et al. The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. Journal of Urology2010;184(1):280‐5. [MEDLINE: 20488469] NeveusT , BrandstromP , LinnerT , JodalU , HanssonS . Parental experiences and preferences regarding the treatment of vesicoureteral reflux. Scandinavian Journal of Urology &amp; Nephrology2012;46(1):26‐30. [MEDLINE: 22008041] SillenU , BrandstromP , JodalU , HolmdahlG , SandinA , SjobergI , et al. The Swedish reflux trial in children: v. Bladder dysfunction. Journal of Urology2010;184(1):298‐304. [MEDLINE: 20488486] ">Swedish Reflux 2010</a>; <a href="./references#CD001534-bbs2-0041" title="ZegersB , UiterwaalC , KimpenJ , vanGoolJ , deJongT , Winkler‐SeinstraP , et al. Antibiotic prophylaxis for urinary tract infections in children with spina bifida on intermittent catheterization. Journal of Urology2011;186(6):2365‐70. [MEDLINE: 22019031] ZegersSH , DielemanJ , van derBruggenT , KimpenJ , deJong‐de Vos van SteenwijkC . The influence of antibiotic prophylaxis on bacterial resistance in urinary tract infections in children with spina bifida.[Erratum appears in BMC Infect Dis. 2017 Feb 27;17 (1):175; PMID: 28241750]. BMC Infectious Diseases2017;17(1):63. [MEDLINE: 28081719] ">Zegers 2011</a>) or other urological abnormality (<a href="./references#CD001534-bbs2-0030" title="MadsenST . Trimethoprim + sulphamethoxazole in urinary tract infections. Scandinavian Journal of Urology &amp; Nephrology1973;7(2):184‐6. [MEDLINE: 4586340] ">Madsen 1973</a>). Five studies didn't compare antibiotics with placebo/no treatment or with another antibiotic (<a href="./references#CD001534-bbs2-0018" title="BoseW , KaramaA , LinzenmeierG , OlbingH , WellmannP . Controlled trial of co‐trimoxazole in children with urinary tract infection: bacteriological efficacy and haematological toxicity. Lancet1974;2(7881):614‐6. [MEDLINE: 4137593] ">Bose 1974</a>; <a href="./references#CD001534-bbs2-0019" title="ClementeE , SolliR , MeiV , CeraR , CaramiaG , CarnelliV , et al. Therapeutic efficacy and safety of pidotimod in the treatment of urinary tract infections in children. Arzneimittel‐Forschung1994;44(12A):1490‐4. [MEDLINE: 7857349] ">Clemente 1994</a>; <a href="./references#CD001534-bbs2-0020" title="CraigJ , RoyL , SureshkumarP , BurkeJ , PowellH . Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo‐controlled randomized trial [abstract no: F‐FC014]. Journal of the American Society of Nephrology2002;13(September, Program &amp; Abstracts):3A. [CENTRAL: CN‐00444938] CraigJC , RoyLP , SureshkumarP , BurkeJ , PowellH , HodsonEM . Long‐term antibiotics to prevent urinary tract infection in children with isolated vesicoureteric reflux: a placebo controlled randomized trial [abstract no: 44]. American Society of Nephrology2002;7(Suppl 3):A55. [CENTRAL: CN‐00444937] ">Craig 2002</a>; <a href="./references#CD001534-bbs2-0031" title="MarildS , EsbjornerE , KakobssonB , LinneT , LubeckP , SjogrenI , et al. Randomised study of ceftibuten vs trimethoprim‐sulfamethoxazole in pyelonephritis in children [abstract no: P466]. Pediatric Nephrology2004;19(9):C208. MarildS , JodalU , SandbergT . Ceftibuten versus trimethoprim‐sulfamethoxazole for oral treatment of febrile urinary tract infection in children. Pediatric Nephrology2009;24(3):521‐6. [MEDLINE: 18818954] ">Marild 2009</a>; <a href="./references#CD001534-bbs2-0033" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] LaScolaC , DeMutiisC , HewittIK , PuccioG , ToffoloA , ZucchettaP , et al. Different guidelines for imaging after first UTI in febrile infants: yield, cost, and radiation. Pediatrics2013;131(3):e665‐71. [MEDLINE: 23439905] MontiniG , MurerL , GobberD , ComacchioS , ToffoloA , Dall'AmicoR , et al. Oral vs initial intravenous antibiotic treatment of urinary tract infections in children: a multicentre study [abstract no: W833]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816‐7. [CENTRAL: CN‐00446817] MontiniG , ToffoloA , ZucchettaP , Dall'AmicoR , GobberD , CalderanA , et al. Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non‐inferiority trial. BMJ2007;335(7616):386‐8. [MEDLINE: 17611232] MontiniG , ZucchettaP , GobberD , MurerL , RigonL , ToffoloA , et al. Usefulness of renal radiology and scintigraphy in children with a first episode of upper urinary tract infection [abstract]. Nephrology Dialysis Transplantation2003;18(Suppl 4):813. [CENTRAL: CN‐00446818] MontiniG , ZucchettaP , TomasiL , TalentiE , RigamontiW , PiccoG , et al. Value of imaging studies after a first febrile urinary tract infection in young children: data from Italian renal infection study 1. Pediatrics2009;123(2):e239‐46. [MEDLINE: 19139086] ">Montini 2007</a>) and six studies were of short duration or acute treatment (<a href="./references#CD001534-bbs2-0017" title="BergstromT , LincolnK , RedinB , WinbergJ . Studies of urinary tract infections in infancy and childhood. X. Short or long term treatment in girls with first or second time urinary tract infections uncomplicated by obstructive urological abnormalities. Acta Paediatrica Scandinavica1968;57(3):186‐194. [MEDLINE: 4884133] ">Bergstrom 1968</a>; <a href="./references#CD001534-bbs2-0023" title="FennellRS , LuengnaruemitchaiM , IravaniA , GarinEH , WalkerRD , RichardGA . Urinary tract infections in children: effect of short course antibiotic therapy on recurrence rate in children with previous infections. Clinical Pediatrics1980;19(2):121‐4. [MEDLINE: 7351102] ">Fennell 1980</a>; <a href="./references#CD001534-bbs2-0024" title="FischbachM , SimeoniU , MengusL , JehlF , MonteilH , GeisertJ , et al. Urinary tract infections with tissue penetration in children: cefotaxime compared with amoxycillin/clavulanate. Journal of Antimicrobial Chemotherapy1989;24 Suppl B:177‐83. [MEDLINE: 2691478] ">Fischbach 1989</a>; <a href="./references#CD001534-bbs2-0025" title="GarinE , OlavariaF , Garcia NietoV , Valenciano FuenteB . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis [abstract no: FP‐3‐1]. Pediatric Nephrology2007;22(7):1070. [CENTRAL: CN‐00724967] GarinEH , OlavarriaF , Garcia NietoV , ValencianoB , CamposA , YoungL . Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics2006;117(3):626‐32. [MEDLINE: 16510640] ">Garin 2006</a>; <a href="./references#CD001534-bbs2-0029" title="LindbergU , ClaessonI , HansonLA , JodalU . Asymptomatic bacteriuria in schoolgirls. VIII. Clinical course during a 3 year follow‐up. Journal of Pediatrics1978;92(2):194‐9. [MEDLINE: 340626] ">Lindberg 1978</a>; <a href="./references#CD001534-bbs2-0035" title="PisaniE , Pavone‐MacalusoM , RoccoF , PiaiaF , PirozziF , RotoloU , et al. Kelfiprim, a new sulpha‐trimethoprim combination, versus cotrimoxazole, in the treatment of urinary tract infections: a multicentre, double‐blind trial. Urological Research1982;10(1):41‐4. [MEDLINE: 7041395] ">Pisani 1982</a>). </p> <p>Non‐randomised studies were removed from the 2018 review update.</p> <p>See <a href="./references#CD001534-sec2-0022" title="">Characteristics of excluded studies</a> </p> </section> </section> <section id="CD001534-sec2-0009"> <h3 class="title">Risk of bias in included studies</h3> <p>Prior to the 2011 update, analysed studies were poorly reported for methodological detail. <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> was published initially in abstract form and in the 2011 update a full journal article of the study was included with much greater methodological detail (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>). One large, recent study (<a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) was well designed, well reported and powered appropriately for the study question (<a href="#CD001534-fig-0002">Figure 2</a>; <a href="#CD001534-fig-0003">Figure 3</a>). Three of the four studies added in the 2018 update (<a href="./references#CD001534-bbs2-0001" title="AntachopoulosC , IonnidouM , TratselasA , IosifidisE , KatragkouA , KadiltzoglouP , et al. Comparison of cotrimoxazole vs. second‐generation cephalosporins for prevention of urinary tract infections in children. Pediatric Nephrology2016;31(12):2271‐76. [MEDLINE: 27525699] ">Antachopoulos 2016</a>; <a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a>; <a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>) were very poorly reported with all having the majority of risk of bias fields designated as unclear because details were missing from the report. <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a> was reported more completely however blinding, incomplete outcomes reporting and selective reporting fields were designated as having a high risk of bias. </p> <div class="figure" id="CD001534-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001534-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001534-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001534-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD001534-sec3-0019"> <h4 class="title">Allocation</h4> <section id="CD001534-sec4-0008"> <h5 class="title">Random sequence generation</h5> <p>Five studies (<a href="./references#CD001534-bbs2-0009" title="LeggtenB , TrosterK . Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin [Reinfektionsprophylaxe rezidivierender Harnwegsinfektionen im Kindesalter ‐ Ergebnisse einer offenen, kontrollierten und randomisierten Studie zur Wirksamkeit und Vertraglichkeit von Cefixim im Vergleich zu Nitrofurantoin]. Klinische Padiatrie2002;214(6):353‐8. [MEDLINE: 12424684] ">Lettgen 2002</a>; <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>) reported how the randomisation sequence was generated and appeared robust. The remaining 11 studies did not provide sufficient details about the process to understand the methods used. </p> </section> <section id="CD001534-sec4-0009"> <h5 class="title">Allocation concealment</h5> <p>Six studies (<a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a>; <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>; <a href="./references#CD001534-bbs2-0011" title="LohrJA , NunleyDH , HowardsSS , FordRF . Prevention of recurrent urinary tract infections in girls. Pediatrics1977;59(4):562‐5. [MEDLINE: 322082] ">Lohr 1977</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>) reported that allocation to treatment group was concealed and unable to be influenced by the treating physician. For the remaining 10 studies this was unclear. </p> </section> </section> <section id="CD001534-sec3-0020"> <h4 class="title">Blinding</h4> <p>Four studies stated that they were double‐blinded or that patients and clinicians were blinded to treatment allocation (<a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a>; <a href="./references#CD001534-bbs2-0011" title="LohrJA , NunleyDH , HowardsSS , FordRF . Prevention of recurrent urinary tract infections in girls. Pediatrics1977;59(4):562‐5. [MEDLINE: 322082] ">Lohr 1977</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>). Five studies stated that there was no blinding (<a href="./references#CD001534-bbs2-0002" title="BaciulisV , EitutieneG , BaciulieneE , CerkauskieneR , JankauskieneA . Long‐term cefadroxil prophylaxis in children with recurrent urinary tract infections [abstract no: W832]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816. BaciulisV , EitutieneG , CerkauskieneR , BaciulieneE , JankauskieneA , MieliauskaiteE . Long term cefadroxil prophylaxis in children with recurrent urinary tract infections [Vaiku pasikartojancios slapimo organu infekcijos ilgalaikis profilaktinis gydymas cefadroksiliu]. Medicina2003;39(Suppl 1):59‐63. [MEDLINE: 12761422] ">Baciulis 2003</a>; <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>) and for seven studies (<a href="./references#CD001534-bbs2-0001" title="AntachopoulosC , IonnidouM , TratselasA , IosifidisE , KatragkouA , KadiltzoglouP , et al. Comparison of cotrimoxazole vs. second‐generation cephalosporins for prevention of urinary tract infections in children. Pediatric Nephrology2016;31(12):2271‐76. [MEDLINE: 27525699] ">Antachopoulos 2016</a>; <a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a>; <a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a>; <a href="./references#CD001534-bbs2-0006" title="CarlsenNL , HesselbjergU , GlentingP . Comparison of long‐term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children: an open, randomized, cross‐over study. Journal of Antimicrobial Chemotherapy1985;16(4):509‐17. [MEDLINE: 4066562] ">Carlsen 1985</a>; <a href="./references#CD001534-bbs2-0007" title="FalakaflakiB , FallahR , JamshidiMR , MoeziF , TorabiZ . Comparison of nitrofurantoin and trimethoprim‐sulphamethoxazole for long‐term prophylaxis in children with recurrent urinary tract infections. International Journal of Pharmacology2007;3(2):179‐82. [EMBASE: 2007450479] ">Falakaflaki 2007</a>; <a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001534-bbs2-0009" title="LeggtenB , TrosterK . Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin [Reinfektionsprophylaxe rezidivierender Harnwegsinfektionen im Kindesalter ‐ Ergebnisse einer offenen, kontrollierten und randomisierten Studie zur Wirksamkeit und Vertraglichkeit von Cefixim im Vergleich zu Nitrofurantoin]. Klinische Padiatrie2002;214(6):353‐8. [MEDLINE: 12424684] ">Lettgen 2002</a>) blinding of patients and clinicians was unclear. Only <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> stated that outcome assessors were blinded to treatment allocation. <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a> stated no blinding for outcomes and for the remaining 14 studies this detail was not reported. </p> </section> <section id="CD001534-sec3-0021"> <h4 class="title">Incomplete outcome data</h4> <p>Six studies provided explanations for changes in numbers of children reported at the start and finish of the studies (<a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>). For four studies (<a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a>; <a href="./references#CD001534-bbs2-0006" title="CarlsenNL , HesselbjergU , GlentingP . Comparison of long‐term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children: an open, randomized, cross‐over study. Journal of Antimicrobial Chemotherapy1985;16(4):509‐17. [MEDLINE: 4066562] ">Carlsen 1985</a>; <a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>; <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>) numbers reported were inconsistent for the start and finish of the study or varied across the reported outcomes without explanation, placing the study at high risk of bias. For six studies it was unclear whether everyone who started the study was included in the final analysis giving them an assessment of unclear bias. </p> </section> <section id="CD001534-sec3-0022"> <h4 class="title">Selective reporting</h4> <p>Eight studies reported the most appropriate primary outcome, repeat symptomatic UTI for the question (<a href="./references#CD001534-bbs2-0001" title="AntachopoulosC , IonnidouM , TratselasA , IosifidisE , KatragkouA , KadiltzoglouP , et al. Comparison of cotrimoxazole vs. second‐generation cephalosporins for prevention of urinary tract infections in children. Pediatric Nephrology2016;31(12):2271‐76. [MEDLINE: 27525699] ">Antachopoulos 2016</a>; <a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a>; <a href="./references#CD001534-bbs2-0007" title="FalakaflakiB , FallahR , JamshidiMR , MoeziF , TorabiZ . Comparison of nitrofurantoin and trimethoprim‐sulphamethoxazole for long‐term prophylaxis in children with recurrent urinary tract infections. International Journal of Pharmacology2007;3(2):179‐82. [EMBASE: 2007450479] ">Falakaflaki 2007</a>; <a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a>, <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>), while five studies reported a less relevant primary outcome of repeat positive urine culture. In three studies it was not clear whether the reported outcome was symptomatic or asymptomatic UTI, hence these were classified as unclear for selective reporting bias (<a href="./references#CD001534-bbs2-0002" title="BaciulisV , EitutieneG , BaciulieneE , CerkauskieneR , JankauskieneA . Long‐term cefadroxil prophylaxis in children with recurrent urinary tract infections [abstract no: W832]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816. BaciulisV , EitutieneG , CerkauskieneR , BaciulieneE , JankauskieneA , MieliauskaiteE . Long term cefadroxil prophylaxis in children with recurrent urinary tract infections [Vaiku pasikartojancios slapimo organu infekcijos ilgalaikis profilaktinis gydymas cefadroksiliu]. Medicina2003;39(Suppl 1):59‐63. [MEDLINE: 12761422] ">Baciulis 2003</a>; <a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a>; <a href="./references#CD001534-bbs2-0011" title="LohrJA , NunleyDH , HowardsSS , FordRF . Prevention of recurrent urinary tract infections in girls. Pediatrics1977;59(4):562‐5. [MEDLINE: 322082] ">Lohr 1977</a>). </p> </section> <section id="CD001534-sec3-0023"> <h4 class="title">Other potential sources of bias</h4> <p>For many studies it was difficult to determine who the children were and how many were reviewed for possible inclusion in the study and therefore the ability to determine the extent of selection bias was very limited. Only <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> clearly reported the number of patients screened and the reasons for exclusion and non‐enrolment. </p> <p>Definitions and criteria for diagnosis of initial and recurrent UTI differed enormously between the studies and were generally poorly reported. Misclassification was possible in most studies and largely ignored. </p> </section> </section> <section id="CD001534-sec2-0010"> <h3 class="title" id="CD001534-sec2-0010">Effects of interventions</h3> <p>See: <a href="./full#CD001534-tbl-0001"><b>Summary of findings for the main comparison</b> Antibiotic treatment versus placebo or no treatment</a>; <a href="./full#CD001534-tbl-0002"><b>Summary of findings 2</b> Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</a> </p> <section id="CD001534-sec3-0024"> <h4 class="title">Antibiotics versus placebo/no treatment</h4> <section id="CD001534-sec4-0010"> <h5 class="title">Recurrence of symptomatic UTI</h5> <p>Of the seven studies comparing antibiotic treatment with placebo/no treatment, five studies, involving 1074 children contained data for the outcome repeat symptomatic UTI and could be pooled and analysed. The resulting estimated risk of repeat symptomatic UTI suggests a 25% reduction in risk of repeat symptomatic UTI for children taking antibiotics (RR 0.75, <a href="./references#CD001534-fig-00101" title="">Analysis 1.1</a>). However the precision of the estimate was low (95% CI 0.28 to 1.98) and includes no difference in risk between the treatment groups. Heterogeneity was high (I<sup>2</sup> = 94%) and this reflects the variability in the early studies and leads to the level of certainty around this evidence as being low (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). Notable in this analysis was the difference in quality of included studies. A single study (<a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) used a placebo and blinding and had a low risk of bias across all other fields while the remaining four studies were unblinded, did not use a placebo and were unclear or had design issues putting them at a high risk of bias. <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a> and <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> compared trimethoprim‐sulphamethoxazole with no treatment/placebo while the three other studies compared two or three different antibiotics with no treatment. </p> <p>One study comparing antibiotics with no treatment was a cross‐over design (<a href="./references#CD001534-bbs2-0011" title="LohrJA , NunleyDH , HowardsSS , FordRF . Prevention of recurrent urinary tract infections in girls. Pediatrics1977;59(4):562‐5. [MEDLINE: 322082] ">Lohr 1977</a>) and did not provide data on the first phase, thus could not be included in the meta‐analyses. Another study (<a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>) could not be included in the pooled analysis because they did not report the outcome of repeat symptomatic UTI. </p> <section id="CD001534-sec5-0001"> <h6 class="title">Presence of VUR and recurrence of symptomatic UTI</h6> <p>Four studies reported separate data for children with and without VUR (<a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>; <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>). The summary point estimate for children without VUR was RR 0.60 (<a href="./references#CD001534-fig-00102" title="">Analysis 1.2</a>.1: 95% CI 0.13 to 2.174; RD ‐7%, 95% CI ‐19 to 4) suggesting a reduced risk of repeat symptomatic UTI in those on antibiotic prophylaxis compared to those on placebo/no treatment but with considerable imprecision and leading to a low level of certainty (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). The two recent and the most robustly designed studies (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) reported findings for a subset of children who had VUR with the estimate being RR 0.65 and was more precise, leading to an assessment of high certainty around this evidence (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>) (<a href="./references#CD001534-fig-00102" title="">Analysis 1.2</a>.2: RR 0.65, 95% CI 0.39 to 1.07; RD 6%, 95% CI ‐14 to ‐1). Despite the study design quality differences, the estimates for risk in children with VUR and those without VUR were remarkably similar (RR 0.60 and RR 0.65) showing little difference between antibiotic and placebo/no treatment in the different groups of children. </p> </section> <section id="CD001534-sec5-0002"> <h6 class="title">Study design and risk of bias</h6> <p>Two studies had adequate allocation concealment (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) and gave a point estimate with high precision and a high level of certainty (<a href="./references#CD001534-fig-00103" title="">Analysis 1.3</a>.1: RR 0.68, 95% CI 0.48 to 0.95; RD ‐5%, 95% CI ‐9 to 0) (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>) while the three studies with unclear allocation concealment (<a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>, <a href="./references#CD001534-bbs2-0010" title="LiernM , MaldonadoL , JordanP , VallejoG . Recurrent urinary tract infections: predisposing factors and antibiotic profilaxis [Infecciones urinarias recurrentes: Factores predisponentes y profilaxis antibiotica]. Revista de Nefrología, Diálisis y Transplante2011;31(1):22‐9. [EMBASE: 2012397309] ">Liern 2011</a>) showed considerable imprecision (<a href="./references#CD001534-fig-00103" title="">Analysis 1.3</a>.2: RR 0.58, 95% CI 0.05 to 6.41; RD ‐10%, 95% CI ‐40 to 19). </p> <p>A single study was appropriately blinded (<a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) and the point estimate is more precise than that of the three unblinded studies (<a href="./references#CD001534-fig-00103" title="">Analysis 1.3</a>.3: RR 0.65, 95% CI 0.44 to 0.96; RD ‐7%, 95% CI ‐13 to ‐1 compared to <a href="./references#CD001534-fig-00103" title="">Analysis 1.3</a>.4: RR 0.72, 95% CI 0.18 to 2.84; RD ‐7%, 95% CI ‐20 to 7). </p> </section> </section> <section id="CD001534-sec4-0011"> <h5 class="title">Repeat positive urine culture</h5> <p>Compared to placebo/no treatment, antibiotics appeared to moderately reduce the risk of repeat positive urine culture (<a href="./references#CD001534-fig-00104" title="">Analysis 1.4</a>.1: RR 0.31, 95% CI 0.08 to 1.18; RD ‐28% 95% CI ‐51 to ‐5) (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0014" title="SavageDC , HowieG , AdlerK , WilsonMI . Controlled trial of therapy in covert bacteriuria of childhood. Lancet1975;1(7903):358‐61. [MEDLINE: 46511] SavageDC , WilsonMI , McHardyM , DewarDA , FeeWM . Covert bacteriuria of childhood. A clinical and epidemiological study. Archives of Disease in Childhood1973;48(1):8‐20. [MEDLINE: 4685601] ">Savage 1973</a>; <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>) however the precision is poor and shows there may be little or no difference in risk between those taking antibiotics and those not treated. Studies showed substantial heterogeneity (I<sup>2</sup> = 91%) and there was considerable variability in the rates of repeat positive urine cultures in the control groups of the four studies, ranging from 21% to 85%. This suggests a very low level of certainty in this evidence (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Studies with adequate allocation concealment showed a reduced risk of repeat positive culture (RR of 0.21, 95% CI 0.2 to 2.5; RD ‐29%, 95% CI ‐68 to 11) (<a href="./references#CD001534-fig-00105" title="">Analysis 1.5</a>.1) but precision was poor and includes the estimate of no difference between the groups. Studies with inadequate or unclear allocation concealment had the same RR (0.21) but much larger 95% CI, indicating much greater imprecision (95% CI 0.00 to 32.38; RD ‐28%, 95% CI ‐71 to 15) (<a href="./references#CD001534-fig-00105" title="">Analysis 1.5</a>.2). One study stated that it was blinded and their results gave a substantially reduced risk of repeat positive culture in the antibiotic group (RR of 0.05, 95% CI 0.0 to 0.72; RD ‐50%, 95% CI ‐71 to ‐29) (<a href="./references#CD001534-fig-00105" title="">Analysis 1.5</a>.3) while studies that described an open study or unclear blinding, gave a somewhat reduced risk of repeat positive culture (RR of 0.48, 95% CI 0.15 to 1.54; RD ‐21%, 95% CI ‐44 to 3) (<a href="./references#CD001534-fig-00105" title="">Analysis 1.5</a>.4) but this estimate includes a risk of no difference. </p> </section> <section id="CD001534-sec4-0012"> <h5 class="title">Adverse events</h5> <p>Two studies reported adverse events within each treatment arm (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>), with very different findings. The unblinded study (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>) showed no events in the no‐treatment arm and <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> showed more events in the placebo arm than the active arm. The risk of adverse events was estimated as twice as likely in children taking placebo or not treated compared to those on antibiotics (RR 2.31) but imprecision was very high and our certainty around this evidence is low (95% CI 0.03 to 170.67; RD 2%, 95% CI 7 to 11) (<a href="./references#CD001534-fig-00106" title="">Analysis 1.6</a>.1) (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> <section id="CD001534-sec4-0013"> <h5 class="title">Microbial resistance</h5> <p>Three studies reported results for microbial resistance (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>; <a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>). Two of these reported for repeat symptomatic UTI (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) and showed a much increased risk of bacterial resistance to the active treatment in children taking antibiotics (RR of 2.40, 95% CI 0.62 to 9.26; RD 25%, 95% CI ‐9 to 60) (<a href="./references#CD001534-fig-00107" title="">Analysis 1.7</a>) meaning resistance was more than twice as likely in the active treatment arms than the non‐treatment or placebo groups. The third study with the outcome repeat positive urine culture, showed a single positive culture with resistant bacteria in the placebo group (<a href="./references#CD001534-bbs2-0016" title="StansfeldJM . Duration of treatment for urinary tract infections in children. British Medical Journal1975;3(5975):65‐6. [MEDLINE: 1095132] ">Stansfeld 1975</a>). Overall this evidence provides a moderate level of certainty (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). </p> </section> </section> <section id="CD001534-sec3-0025"> <h4 class="title">Comparison between two antibiotics</h4> <p>Five studies provided data to compare one antibiotic with another antibiotic (<a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a>; <a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a>; <a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a>; <a href="./references#CD001534-bbs2-0007" title="FalakaflakiB , FallahR , JamshidiMR , MoeziF , TorabiZ . Comparison of nitrofurantoin and trimethoprim‐sulphamethoxazole for long‐term prophylaxis in children with recurrent urinary tract infections. International Journal of Pharmacology2007;3(2):179‐82. [EMBASE: 2007450479] ">Falakaflaki 2007</a>; <a href="./references#CD001534-bbs2-0009" title="LeggtenB , TrosterK . Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin [Reinfektionsprophylaxe rezidivierender Harnwegsinfektionen im Kindesalter ‐ Ergebnisse einer offenen, kontrollierten und randomisierten Studie zur Wirksamkeit und Vertraglichkeit von Cefixim im Vergleich zu Nitrofurantoin]. Klinische Padiatrie2002;214(6):353‐8. [MEDLINE: 12424684] ">Lettgen 2002</a>), two studies reported their primary outcome as symptomatic UTI and three reported positive urine culture. Almost no data could be combined since studies with the same outcome used different antibiotic comparisons. </p> <section id="CD001534-sec4-0014"> <h5 class="title">Nitrofurantoin versus other antibiotics</h5> <p>For the outcome symptomatic UTI, <a href="./references#CD001534-bbs2-0007" title="FalakaflakiB , FallahR , JamshidiMR , MoeziF , TorabiZ . Comparison of nitrofurantoin and trimethoprim‐sulphamethoxazole for long‐term prophylaxis in children with recurrent urinary tract infections. International Journal of Pharmacology2007;3(2):179‐82. [EMBASE: 2007450479] ">Falakaflaki 2007</a> showed a reduced risk of repeat symptomatic UTI in children taking nitrofurantoin compared to those taking trimethoprim‐sulphamethoxazole (<a href="./references#CD001534-fig-00201" title="">Analysis 2.1</a>.1: RR 0.57, 95% CI 0.35 to 0.92; RD ‐20%, 95% CI ‐36 to 4) with no estimate for <a href="./references#CD001534-bbs2-0015" title="SmellieJM , KatzG , GrunebergRN . Controlled trial of prophylactic treatment in childhood urinary tract infection. Lancet1978;2(8082):175‐8. [MEDLINE: 78382] ">Smellie 1978</a> due to absence of events in both arms. This data provides a moderate level of certainty (<a href="./full#CD001534-tbl-0002">summary of findings Table 2</a>). <a href="./references#CD001534-bbs2-0005" title="BrendstrupL , HjeltK , PetersenKE , PetersenS , AndersenEA , DaugbjergPS , et al. Nitrofurantoin versus trimethoprim prophylaxis in recurrent urinary tract infection in children: a randomized, double‐blind study. Acta Paediatrica Scandinavica1990;79(12):1225‐34. [MEDLINE: 2085111] ">Brendstrup 1990</a> compared nitrofurantoin with trimethoprim and showed a reduced risk of repeat positive urine culture in children taking nitrofurantoin compared to those on trimethoprim (<a href="./references#CD001534-fig-00202" title="">Analysis 2.2</a>.1: RR 0.32, 95% CI 0.19 to 0.56; RD ‐42%, 95% CI ‐58 to ‐26). However, patients receiving nitrofurantoin were twice as likely to experience side effects (nausea, vomiting or stomach ache) than patients receiving trimethoprim (<a href="./references#CD001534-fig-00204" title="">Analysis 2.4</a>.3: RR 2.18, 95% CI 1.39 to 3.41; RD 33%, 95% CI 17 to 50). This suggests that the side effects of nitrofurantoin (NNH = 3, 95% CI 2 to 6) are similar to the prophylactic benefit (NNT = 5, 95% CI 3 to 33) compared with trimethoprim. <a href="./references#CD001534-bbs2-0009" title="LeggtenB , TrosterK . Prophylaxis of recurrent urinary tract infections in children. Results of an open, controlled and randomized study about the efficacy and tolerance of cefixime compared to nitrofurantoin [Reinfektionsprophylaxe rezidivierender Harnwegsinfektionen im Kindesalter ‐ Ergebnisse einer offenen, kontrollierten und randomisierten Studie zur Wirksamkeit und Vertraglichkeit von Cefixim im Vergleich zu Nitrofurantoin]. Klinische Padiatrie2002;214(6):353‐8. [MEDLINE: 12424684] ">Lettgen 2002</a> compared nitrofurantoin with cefixime. For the outcome repeat positive urine culture the risk estimate suggested nitrofurantoin gave a slightly increased risk of repeat positive culture compared to cefixime (<a href="./references#CD001534-fig-00202" title="">Analysis 2.2</a>.2: RR 1.35) however the precision of the estimate was very poor and includes the possibility of no difference between the treatment options (95% CI 0.24 to 7.48; RD 3%, 95% CI ‐12 to 17). </p> <p><a href="./references#CD001534-bbs2-0006" title="CarlsenNL , HesselbjergU , GlentingP . Comparison of long‐term, low dose pivmecillinam and nitrofurantoin in the control of recurrent urinary tract infection in children: an open, randomized, cross‐over study. Journal of Antimicrobial Chemotherapy1985;16(4):509‐17. [MEDLINE: 4066562] ">Carlsen 1985</a>, a cross‐over study, compared nitrofurantoin with pivmecillinam in 32 children. Allocation concealment and blinding were unclear. Ten repeat positive urine cultures occurred during pivmecillinam treatment and six while taking nitrofurantoin. </p> </section> <section id="CD001534-sec4-0015"> <h5 class="title">Other antibiotic comparisons</h5> <p><a href="./references#CD001534-bbs2-0004" title="BeletN , IslekI , BeletU , SunterAT , KucukoduS . Comparison of trimethoprim‐sulfamethoxazole, cephadroxil and cefprozil as prophylaxis for recurrent urinary tract infections in children. Journal of Chemotherapy2004;16(1):77‐81. [MEDLINE: 15078003] ">Belet 2004</a> compared three antibiotics (cotrimoxazole, cefadroxil and cefprozil) with cefadroxil appearing the most effective (<a href="./references#CD001534-fig-00201" title="">Analysis 2.1</a>.3; <a href="./references#CD001534-fig-00201" title="">Analysis 2.1</a>.4; <a href="./references#CD001534-fig-00201" title="">Analysis 2.1</a>.5). No results showed a difference and the study was underpowered (N = 21, 25 and 34) for the small differences in event rates (8%, 14% and 21%). <a href="./references#CD001534-bbs2-0003" title="Beiraghi ToosiM , Ghane‐SharbafF , EsmalaelliM , KhajedalueeM . Comparison of nalidixic acid with trimethoprim‐sulfamethoxazole in prophylaxis of recurring urinary tract infection in children [abstract no: P124]. Iranian Journal of Kidney Diseases2011;5(Suppl 1):12‐3. [EMBASE: 70539629] ">Beiraghi Toosi 2011</a> compared nalidixic acid with trimethoprim‐sulphamethoxazole for the outcome repeat positive urine culture with recurrence twice as likely in children taking nalidixic acid (RR 2.27 95%CI 1.25 to 4.13). </p> </section> </section> <section id="CD001534-sec3-0026"> <h4 class="title">Dose comparisons</h4> <p><a href="./references#CD001534-bbs2-0002" title="BaciulisV , EitutieneG , BaciulieneE , CerkauskieneR , JankauskieneA . Long‐term cefadroxil prophylaxis in children with recurrent urinary tract infections [abstract no: W832]. Nephrology Dialysis Transplantation2003;18(Suppl 4):816. BaciulisV , EitutieneG , CerkauskieneR , BaciulieneE , JankauskieneA , MieliauskaiteE . Long term cefadroxil prophylaxis in children with recurrent urinary tract infections [Vaiku pasikartojancios slapimo organu infekcijos ilgalaikis profilaktinis gydymas cefadroksiliu]. Medicina2003;39(Suppl 1):59‐63. [MEDLINE: 12761422] ">Baciulis 2003</a> compared every night cefadroxil treatment with alternate evening therapy. No difference between the doses was evident (<a href="./references#CD001534-fig-00301" title="">Analysis 3.1</a>: RR 0.9, 95% CI 0.24 to 3.41; RD ‐2%, 95% CI ‐30 to 26). The study was small (N = 33) and methodology was poorly reported. </p> </section> <section id="CD001534-sec3-0027"> <h4 class="title">Circumcision</h4> <p><a href="./references#CD001534-bbs2-0008" title="BurguB , GokceI , AydogduO , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR? [abstract no: 574]. Journal of Urology2011;185(4 Suppl 1):e231. [EMBASE: 70377838] GucukA , BurguB , GokceI , MermerkayaM , SoygurT . Do antibiotic prophylaxis and/or circumcision change periurethral uropathogen colonization and urinary tract infection rates in boys with VUR?. Journal of Pediatric Urology2013;9(6 Pt B):1131‐6. [MEDLINE: 23721792] ">Gucuk 2013</a> randomised boys with VUR and boys without VUR into different treatment options and therefore the findings across the VUR group and non‐VUR group could not be compared. Boys with VUR were randomised to antibiotics plus circumcision or antibiotics alone, while boys without VUR were randomised to circumcision alone or no treatment. None of the 45 boys with VUR who were circumcised and treated with antibiotics for 12 months experienced a repeat symptomatic UTI while 6/46 treated with antibiotics for 12 months experienced a repeat symptomatic UTI. In the boys without VUR, none of the 47 circumcised boys and none of the 49 not treated boys experienced a repeat symptomatic UTI during 12 months of follow‐up. </p> </section> <section id="CD001534-sec3-0028"> <h4 class="title">Cross‐over studies, excluded from meta‐analyses</h4> <p>In none of the cross‐over studies was it possible to determine what outcomes occurred before the cross‐over, so none were included in any meta‐analyses. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001534-sec1-0006" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001534-sec1-0006"></div> <section id="CD001534-sec2-0011"> <h3 class="title" id="CD001534-sec2-0011">Summary of main results</h3> <p>Long‐term, low dose antibiotics were associated with a modest decrease in the number of repeat symptomatic UTI in children; however the estimate from combining all studies was not precise or certain (<a href="./full#CD001534-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>Low dose antibiotics taken for 12 months reduced the risk of repeat symptomatic UTI in children by around 6%, which means a baseline risk of recurrence of 20% is reduced to 14%. This treatment was also associated with a more than doubling of the risk that a repeat infection was caused by a bacteria resistant to the treatment antibiotic. </p> <p>Nitrofurantoin appeared to be the most effective antibiotic treatment for UTI prevention; however it was associated with more adverse events than trimethoprim‐sulphamethoxazole </p> </section> <section id="CD001534-sec2-0012"> <h3 class="title" id="CD001534-sec2-0012">Overall completeness and applicability of evidence</h3> <p>The two largest studies in this review reported data and study design details with a high degree of completeness. These studies also included a range of children who are likely to represent the population of children in whom this treatment may be considered. Early studies were far more selective in the type of children included and reported design detail much less thoroughly than later studies. </p> <p>Two earlier versions of this review (<a href="./references#CD001534-bbs2-0060" title="WilliamsGJ , LeeA , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2001, Issue 4. [DOI: 10.1002/14651858.CD001534] ">Williams 2001</a>; <a href="./references#CD001534-bbs2-0061" title="WilliamsG , WeiL , LeeA , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD001534.pub2] ">Williams 2006</a>) concluded that the evidence to support the use of antibiotics to prevent recurrent symptomatic UTI was weak. The update in 2011 (<a href="./references#CD001534-bbs2-0062" title="WilliamsG , CraigJC . Long‐term antibiotics for preventing recurrent urinary tract infection in children. Cochrane Database of Systematic Reviews2011, Issue 3. [DOI: 10.1002/14651858.CD001534.pub3] ">Williams 2011</a>) added data from two large and well reported studies that changed this conclusion (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>). <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> was optimally designed with all features of good design reported in the article (randomisation process, allocation concealment, blinding, explanations for incomplete data, appropriate outcome reporting, and consideration for other bias). <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>, while somewhat smaller, unblinded and with no placebo treatment, gave a RR (0.75) that was reasonably consistent with results from the <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> (RR 0.65); only the <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> reached a degree of precision and certainty for a benefit to antibiotic treatment. These estimates are the least biased and therefore likely to reflect the true effect of prophylactic antibiotic treatment. In the 2018 update four additional studies were included but each provided very limited data for analyses resulting in no change to previous findings. </p> <p>The estimated absolute risk reduction was 6% and corresponds to the need to treat between 16 and 17 children for 12 months to prevent one symptomatic UTI. The absolute treatment effect appears consistent in children with and without VUR, a known risk factor for further UTI. Although antibiotic prophylaxis prevents UTI overall, the data suggest that prolonged treatment results in changes in the susceptibility of pathogenic bacteria with an increased risk of symptomatic UTI caused by bacteria resistant to the prophylactic agent. </p> <p>The smaller and older studies gave highly variable and inconsistent findings, highlighting the effect of poor design and chance effects on study findings. Earlier studies tended to report repeat positive urine culture as their primary outcome and large reductions in the risk of repeat positive urine cultures were found in the antibiotic groups of these studies. However, the appropriateness of this as an outcome is questionable given that few doctors would treat asymptomatic bacteriuria. Further limitations to these studies are the quality of their design. Only two or four studies used adequate allocation concealment and one of four reported double blinding. Our analyses show that the poorly designed studies inflate the treatment effect by 49%, and ranging from 100% to 400% (using <a href="./references#CD001534-fig-00103" title="">Analysis 1.3</a>.2) compared to those with better design. </p> <p>Only <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> reported sufficient detail to identify the time frame for recurrence of symptomatic UTI, in this study 36% of UTIs in the active arm and 47% in the placebo arm occurred within three months of randomisation. A further 19% and 29% (active and placebo arms respectively) of repeat symptomatic UTIs occurred between three and six months post randomisation. This infers that the risk of repeat symptomatic infection is highest during the three months following initial infection and may suggest an initial course of treatment of three months with possible extension to six months. </p> <p>The side effects of active treatment compared to placebo or no treatment were reported in two studies (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>; <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>). The unblinded study (<a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a>) reported 15 events in the active treatment arm and none in the no‐treatment group, while the blinded study (<a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>) showed considerably more events in the placebo arm compared to active treatment (10 versus 4). This suggests interpretation of adverse events is influenced by knowledge of treatment group therefore the blinded study is a more reliable estimate of rates of adverse events. </p> <p>Three studies reported the numbers of urine cultures causing symptomatic UTI that grew bacteria resistant to the active treatment in the studies with placebo comparisons. Two studies reported that 8% of the cultures in the no treatment arm were resistant to the active drug but <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> showed that 18% of urine infections were caused by bacteria resistant to the active treatment. This suggests the baseline risk of resistance in the non‐treated group is not zero and is likely to be closer to 18% given the greater reliability of <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>. <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> and <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> reported bacterial resistance in the active treatment arms, with over half (53%) of UTIs in the active arm in <a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> and 28% of UTIs in the active arm of <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> being attributed to bacteria resistant to the active treatment drug. While the RR is imprecise (2.4), as shown by the large 95% CI (0.62 to 9.26), the risk appears increased. </p> <p>Although nitrofurantoin was more effective than trimethoprim or cotrimoxazole in preventing repeat symptomatic infection or repeat positive urine culture, it was associated with a greater number of side effects. The harmful effects of nitrofurantoin outweigh the prophylactic benefit and suggest that nitrofurantoin may not be an acceptable therapy. Patient compliance would be an important factor to consider in deciding on the use of nitrofurantoin as prophylaxis. </p> <p>The combined analysis of the studies included in this review show there is a small benefit in long‐term antibiotic treatment to prevent repeat symptomatic UTI however this should be weighed up against the likely increased risk of bacterial resistance in subsequent infections, the baseline risk of repeat symptomatic infection and how strongly parents and physicians wish to avoid a possible repeat illness. </p> </section> <section id="CD001534-sec2-0013"> <h3 class="title" id="CD001534-sec2-0013">Quality of the evidence</h3> <p><a href="./references#CD001534-bbs2-0012" title="HewittIK , TomasiL , PavanelloL , MaschioF , MolinariPP , ToffoloA , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring [abstract no: SA‐PO1100]. Journal of the American Society of Nephrology2006;17(Abstracts):804A. [CENTRAL: CN‐00653791] HewittIK , ZucchettaP , RigonL , MaschioF , MolinariPP , TomasiL , et al. Early treatment of acute pyelonephritis in children fails to reduce renal scarring: data from the Italian Renal Infection Study Trials. Pediatrics2008;122(3):486‐90. [MEDLINE: 18762516] MontiniG . Evaluation of the effectiveness of antibiotic prophylaxis in children with a history of upper urinary tract infections: a multi centre randomised study ‐ Protocol. Personal communication2004. MontiniG , RigonL , GobberD , ZucchettaP , MurerL , CalderanA , et al. A randomised controlled trial of antibiotic prophylaxis in children with a previous documented pyelonephritis [abstract no: OFC35]. Pediatric Nephrology2004;19(9):C70. [CENTRAL: CN‐00583479] MontiniG , RigonL , ZucchettaP , FregoneseF , ToffoloA , GobberD , et al. Prophylaxis after first febrile urinary tract infection in children? A multicenter, randomized, controlled, noninferiority trial. Pediatrics2008;122(5):1064‐71. [MEDLINE: 18977988] ">Montini 2008</a> design was less rigorous than <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> in that there was no placebo treatment, no blinding, and the antibiotic treatment could be either of two antibiotics. Awareness of treatment or the absence of treatment may have led to biased interpretation of possible symptoms of a UTI and misclassification of asymptomatic bacteriuria as symptomatic UTI. Different treatment options in the active arm may have led to heterogeneity in findings within that group if the two antibiotics differed in efficacy. </p> <p>Early studies had many design limitations and reported highly variable results.</p> </section> <section id="CD001534-sec2-0014"> <h3 class="title" id="CD001534-sec2-0014">Potential biases in the review process</h3> <p>The two authors of the 2011 and 2018 updates are authors on the <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a> which may have led to a more favourable assessment <a href="./references#CD001534-bbs2-0013" title="CraigJ , HodsonE , ReynoldsG , CarapetisJ , McTaggartS , IrwigL , et al. A placebo‐controlled randomised trial of antibiotics for the prevention of urinary tract infection in children [abstract no: SA‐PO3072]. Journal of the American Society of Nephrology2008;19(Abstracts Issue):808A. CraigJ , SimpsonJ , LoweA , ReynoldsG , McTaggartS , HodsonE , et al. A placebo‐controlled randomized trial of antibiotics for the prevention of urinary tract infection in children [abstract no: 087]. Nephrology2008;13(Suppl 3):A122. [CENTRAL: CN‐00689116] CraigJC , SimpsonJM , WilliamsGJ , LoweA , ReynoldsG , McTaggartSJ , et al. Antibiotic prophylaxis and recurrent urinary tract infection in children.[Erratum appears in N Engl J Med. 2010 Apr 1;362(13):1250]. New England Journal of Medicine2009;361(18):1748‐59. [MEDLINE: 19864673] ">PRIVENT 2009</a>. To address this an independent person reviewed the risk of bias data to identify and correct possible biases. </p> </section> <section id="CD001534-sec2-0015"> <h3 class="title" id="CD001534-sec2-0015">Agreements and disagreements with other studies or reviews</h3> <p>Several other reviews on this topic have been published (<a href="./references#CD001534-bbs2-0045" title="DaiB , LiuY , JiaJ , MeiC . Long‐term antibiotics for the prevention of recurrent urinary tract infection in children: a systematic review and meta‐analysis. Archives of Diseases in Childhood2010;95(7):499‐508. [MEDLINE: 20457696] ">Dai 2010</a>; <a href="./references#CD001534-bbs2-0052" title="LeSaux , PhamB , MoherD . Evaluating the benefits of antimicrobial prophylaxis to prevent urinary tract infections in children: a systematic review. CMAJ Canadian Medical Association Journal2000;163(5):523‐9. [MEDLINE: 11006762] ">Le Saux 2000</a>; <a href="./references#CD001534-bbs2-0053" title="MathewJL . Antibiotic prophylaxis following urinary tract infection in children: a systematic review of randomized controlled trials. Indian Pediatrics2010;47(7):599‐605. [MEDLINE: 20683113] ">Mathew 2010</a>; <a href="./references#CD001534-bbs2-0054" title="MoriR , FitzgeraldA , WilliamsC , TullusK , Verrier‐JonesK , LakhanpaulM . Antibiotic prophylaxis for children at risk of developing urinary tract infection: a systematic review. Acta Pediatrica2009;98(11):1781‐6. [MEDLINE: 19627258] ">Mori 2009</a>) with varying conclusions depending on which studies were included in the analysis. None of these reviews identified additional studies to those considered in this review and were often missing the complete group. Most authors included studies in which the majority of children had VUR making their inclusion criteria different to ours and more similar to the Cochrane review of Interventions for VUR (<a href="./references#CD001534-bbs2-0055" title="NaglerEV , WilliamsG , HodsonEM , CraigJC . Interventions for primary vesicoureteric reflux. Cochrane Database of Systematic Reviews2011, Issue 6. [DOI: 10.1002/14651858.CD001532.pub4] ">Nagler 2011</a>). On the whole these reviews agreed with the current assessments of study quality. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001534-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001534-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001534-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001534-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 1 Recurrence of symptomatic UTI." data-id="CD001534-fig-00101" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 1 Recurrence of symptomatic UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 2 Recurrence of symptomatic UTI: VUR status." data-id="CD001534-fig-00102" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 2 Recurrence of symptomatic UTI: VUR status. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 3 Recurrence of symptomatic UTI: risk of bias fields." data-id="CD001534-fig-00103" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 3 Recurrence of symptomatic UTI: risk of bias fields. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 4 Repeat positive urine culture." data-id="CD001534-fig-00104" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 4 Repeat positive urine culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 5 Repeat positive urine culture: risk of bias fields." data-id="CD001534-fig-00105" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 5 Repeat positive urine culture: risk of bias fields. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 6 Adverse events." data-id="CD001534-fig-00106" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 6 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 7 Microbial resistance to prophylactic drug." data-id="CD001534-fig-00107" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Antibiotic treatment versus placebo/no treatment, Outcome 7 Microbial resistance to prophylactic drug. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00201"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Comparison between two types of antibiotics, Outcome 1 Recurrence of symptomatic UTI." data-id="CD001534-fig-00201" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Comparison between two types of antibiotics, Outcome 1 Recurrence of symptomatic UTI. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00201">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00202"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Comparison between two types of antibiotics, Outcome 2 Repeat positive urine culture." data-id="CD001534-fig-00202" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Comparison between two types of antibiotics, Outcome 2 Repeat positive urine culture. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00202">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00203"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Comparison between two types of antibiotics, Outcome 3 Microbial resistance to prophylactic drugs." data-id="CD001534-fig-00203" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Comparison between two types of antibiotics, Outcome 3 Microbial resistance to prophylactic drugs. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00203">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00204"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Comparison between two types of antibiotics, Outcome 4 Adverse events." data-id="CD001534-fig-00204" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Comparison between two types of antibiotics, Outcome 4 Adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00204">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001534-fig-00301"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/urn:x-wiley:14651858:media:CD001534:CD001534-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_t/tCD001534-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Dose comparison, Outcome 1 Repeat positive urine culture." data-id="CD001534-fig-00301" src="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Dose comparison, Outcome 1 Repeat positive urine culture.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-fig-00301">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/media/CDSR/CD001534/image_n/nCD001534-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD001534-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment versus placebo or no treatment</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antibiotic treatment versus placebo or no treatment</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with previous UTI and most do not have a renal tract abnormality such as VUR<br/> <b>Setting:</b> children in the community presenting to a hospital who have experienced at least one UTI<br/> <b>Intervention:</b> antibiotic treatment<br/> <b>Comparison:</b> placebo/no treatment </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo/no treatment</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic treatment</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>212 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>159 per 1,000<br/> (59 to 420) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.75<br/> (0.28 to 1.98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1074 (5)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All studies comparing antibiotic treatment with placebo or no treatment.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children without VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>223 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>134 per 1,000<br/> (29 to 611) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.60<br/> (0.13 to 2.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>541 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children with VUR</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>180 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>117 per 1,000<br/> (70 to 192) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.65<br/> (0.39 to 1.07) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>371 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2 3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Small sample size because only two studies reported separated data and majority of children did not have VUR </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI in children, in studies with adequate allocation concealment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>161 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>110 per 1,000<br/> (77 to 153) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.68<br/> (0.48 to 0.95) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>914 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<sup>4</sup><br/> MODERATE </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Repeat positive urine culture</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>386 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>120 per 1,000<br/> (31 to 455) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.31<br/> (0.08 to 1.18) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>467 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All adverse events</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>24 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>56 per 1,000<br/> (1 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.31<br/> (0.03 to 170.67) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>914 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drug</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>164 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>394 per 1,000<br/> (102 to 1,000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.40<br/> (0.62 to 9.26) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>118 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> urinary tract infection; <b>VUR:</b> vesicoureteric reflux </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Two studies were consistent with each other but three others were quite variable in their findings </p> <p><sup>2</sup> Several studies were small and results variable, making the confidence intervals wide </p> <p><sup>3</sup> Smaller and older studies were quite variable in their findings, did not use blinding and patient selection was unclear </p> <p><sup>4</sup>One study was open label suggesting interpretation bias </p> <p><sup>5</sup> Studies which did not include symptoms in the diagnosis of UTI are likely to involve misclassification of UTI and asymptomatic bacteriuria </p> <p><sup>6</sup> One study was open label and all adverse events were in the active arm, suggesting interpretation bias </p> <p><sup>7</sup> One study conducted screening cultures and therefore examined more samples that may have been from asymptomatic bacteriuria while also demonstrating the presence of a drug resistant organism </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Antibiotic treatment versus placebo or no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001534-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> children with primarily normal renal tracts who have experienced at least one UTI<br/> <b>Setting:</b> children who have experienced a UTI in the community and are considered for preventative treatment to reduce the risk of further UTIs<br/> <b>Intervention:</b> one type of antibiotic<br/> <b>Comparison:</b> second type of antibiotic </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>No. of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic 2</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with antibiotic 1</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: nitrofurantoin (1) versus cotrimoxazole (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>218 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>124 per 1,000<br/> (76 to 201) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.57<br/> (0.35 to 0.92) (favours nitrofurantoin) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>157 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events were recorded in one study, so a single study provided data on this comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: cotrimoxazole (1) versus cefadroxil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>80 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000<br/> (26 to 776) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.79<br/> (0.33 to 9.70) (favours cefadroxil) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodology details, not a highly relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Recurrence of symptomatic UTI: cotrimoxazole (1) versus cefprozil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>206 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>142 per 1,000<br/> (41 to 492) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.69<br/> (0.20 to 2.39) (favours cotrimoxazole) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodological details, not a very relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Microbial resistance to prophylactic drugs: nitrofurantoin (1) versus cotrimoxazole (2) </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>672 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>363 per 1,000<br/> (208 to 618) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 0.54<br/> (0.31 to 0.92) (favours nitrofurantoin) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> MODERATE <sup>1</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Both studies had limited methodology reported, but were consistent in their findings</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: cotrimoxazole (1) versus cefprozil (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>88 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>143 per 1,000<br/> (32 to 643) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 1.62<br/> (0.36 to 7.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, few methodology details, not a highly relevant comparison</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adverse events: nitrofurantoin (1) versus trimethoprim (2)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>283 per 1,000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>618 per 1,000<br/> (394 to 966) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RR 2.18<br/> (1.39 to 3.41) (favours trimethoprim) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Single study, poorly reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; <b>UTI:</b> urinary tract infection </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High quality:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate quality:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low quality:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low quality:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Both studies reported their methodology very poorly and it was difficult to be certain of design issues </p> <p><sup>2</sup> Single study, no missing data but considerable uncertainty and imprecision </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Antibiotic 1 versus antibiotic 2 for preventing repeat UTI in children</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/full#CD001534-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001534-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic treatment versus placebo/no treatment</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of symptomatic UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 All studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1074</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.28, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Recurrence of symptomatic UTI: VUR status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.24, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Children without VUR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>541</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.13, 2.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Children with VUR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>371</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.39, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Recurrence of symptomatic UTI: risk of bias fields <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Adequate allocation concealment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.48, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Unclear allocation concealment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.05, 6.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Double‐blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.44, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Open label, unblinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>498</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.18, 2.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Repeat positive urine culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 All studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>467</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.08, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Repeat positive urine culture: risk of bias fields <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Adequate allocation concealment studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>383</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.02, 2.50]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Unclear allocation concealment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.00, 32.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Double‐blinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.05 [0.00, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 Open label, unblinded studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.15, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 All adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>914</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.03, 170.67]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Discontinuation of treatment due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>576</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.4 [0.13, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Microbial resistance to prophylactic drug <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.40 [0.62, 9.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Antibiotic treatment versus placebo/no treatment</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001534-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Comparison between two types of antibiotics</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Recurrence of symptomatic UTI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>317</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.40, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Nitrofurantoin versus cotrimoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>157</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.35, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Cotrimoxazole versus cefadroxil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.33, 9.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Cotrimoxazole versus cefprozil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.20, 2.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Cefadroxil versus cefprozil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [0.09, 1.71]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Repeat positive urine culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.21, 4.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Nitrofurantoin versus trimethoprim</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.19, 0.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Nitrofurantoin versus cefixime</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.24, 7.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 Nalidixic acid versus cotrimoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.27 [1.25, 4.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Microbial resistance to prophylactic drugs <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nitrofurantoin versus cotrimoxazole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.31, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Cotrimoxazole versus cefprozil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Nitrofurantoin versus cefixime</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Nitrofurantoin versus trimethoprim</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 Discontinuation of treatment due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Comparison between two types of antibiotics</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001534-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dose comparison</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Repeat positive urine culture <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Dose comparison</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001534.pub4/references#CD001534-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001534.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD001534-note-1213">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001534-note-1210">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001534-note-1211">Français</a> </li> <li class="section-language"> <a class="" href="ms#CD001534-note-1208">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pt#CD001534-note-1207">Português</a> </li> <li class="section-language"> <a class="" href="ru#CD001534-note-1206">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001534-note-1209">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001534-note-1212">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001534\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001534\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001534\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001534\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001534\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=IYhCEbRn&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001534.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001534.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001534.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001534.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001534.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715095763"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001534.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715095767"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001534.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d7ebe4b4f1bde',t:'MTc0MDcxNTA5Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 